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List of Abbreviations 
 
ABC    ATP binding cassette 
AIF   Apoptosis inducing factor 
ALA   δ-aminolevulinic acid 
AO    Acridine-orange 
BACE2  β-site APP-cleaving enzyme 2 
CPIII   Coproporphyrin III 
CYP   Cytochrome P450 oxygenase 
DSB   Double strand brake 
DUH   Dyschromatosis universalis hereditaria 
EEA1   Early endosome antigen 1 
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FACS   Fluorescence-activated cell sorting 
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Fech   Ferrochelatase 
FISH   Fluorescent in situ hybridization 
FP   Familial pseudohyperkalemia 
GFAAS  Graphite furnace atomic absorption spectrometry  
HDR   Homology drived recombination 
HMT-1  Heavy Metal Transporter factor-1  
KO   Knockout 
LAMP1  Lysosomal-associated membrane protein 1 
Lan   Langereis blood group 
LRO   Lysosome-related organelle 
MDR   Multidrug resistance 
mtABC3  Mitochondrial ABC protein 3 
NBD   Nucleotide binding domain 
NHEJ   Non-homologous end-joining 
Ntrg   Non-target 
PC   Phytochelatin 
PCS   Phytochelatin synthase 
PMEL   Pre-melanosomal protein 
PPIX   Protoporphyrin IX 
PRP   P-glycoprotein related protein 
Rab   Ras-associated binding proteins 
RCAS1  Receptor-binding cancer-associated surface antigen 
ROS   Reactiv oxigene species 
RPE   Retinal pigment epithelium 
RUSH   Retention Using Selective Hooks 
Sa   Streptavidin 
SA   Succinyl-acetone 
SBP   Strepavidine-binding protein 
TMD   Trasmembrane domain 
TRP-1   Tyrosinase-related protein-1  
UMAT  Ubiquitously expressed mammalian ABC half-transporter 






1.1. ABC protein family 
Transporter proteins relocate substances across biological membranes to provide 
the appropriate concentration of molecules. Active transport is catalyzed by one of three 
energy sources: electrochemical or osmotic gradients or the hydrolysis of ATP. ATP 
binding cassette (ABC) transporters use ATP to mediate the energy-dependent movement 
of structurally diverse compounds across membrane barriers. The ABC superfamily is 
one of the largest protein families, performing diverse functions in organisms such as 
bacteria, fungi, plants, and members of the animal kingdom. ABC genes are widely 
dispersed in eukaryotic genomes and are highly conserved between species. The human 
ABC transporter superfamily lists 48 members and based on sequence and structure 
homology they are distributed into seven subfamilies (A-G)1. 
 
1.1.1. Structural determinants of function  
A functional ABC protein typically contains two nucleotide binding domains 
(NBD) and two transmembrane domains (TMD) (Fig. 1A,B). The protein is a full 
transporter if the two NBDs and two TMDs are encoded in one polypeptide chain, but in 
case of half-transporters such as ABCB6, two polypeptide chains form a functional unit 
through dimerization. TMDs have low homology and are responsible for substrate 
binding and translocation, while NBDs are highly conserved and participate in ATP 
binding and hydrolysis. The NBD can be further divided into a RecA-like domain and a 
helical domain. RecA contains two characteristic motifs found in all ATP-binding 
proteins. The Walker motifs (A and B) are separated by ∼90–120 amino acids and are 
involved in nucleotide binding. Signature A (or P-loop: GXXGXFKS; X can represent 
any amino acid) is responsible for H-bond formation with the α, β and γ phosphates, 
while the aromatic residues of A-loop interact with the adenine ring of ATP. The A-loop 
is found about 25 amino acids upstream of the Walker A motif. In signature B (hhhhDE, 
h represents any hydrophobic amino acid) the aspartate residue coordinates magnesium 
ions, and the glutamate is essential for ATP hydrolysis. ABC transporters contain an extra 
element, the signature C motif (LSGGQ) is placed opposite to the walker A and B of 




contains 6–11 membrane-spanning α-helices and provides the substrate specificity. 
Contrary to the nucleotide binding domain, the transmembrane domain has significant 
sequential plasticity between different ABC proteins, but based on X-ray crystallization 
studies, the structures are remarkably similar. The two TMDs together form a cavity in 
the plane of the membrane, thus forming the translocation channel and the substrate 
binding pocket (Fig. 1). The crystal structures of full length ABC transporters have 
provided a plausible mechanism for coupling ATP hydrolysis to transport. Effective 
coupling requires the transmission of the molecular motion from the NBDs to the TMDs. 
At this interface, architecturally conserved α-helices, which are part of the TMDs, are 
present in all reported crystal structures. These ‘coupling helices’ interact with grooves 
formed at the boundaries of the two sub-domains of the NBDs3. 
 
  
Figure 1. Architecture of ABC transporters A Domain arrangement of ABC transporters. Two 
NBDs and two TMDs form a functional transporter. B Conserved and functionally critical motifs 
of a single NBD: residues of the P loop are responsible for H-bond formation with the α, β and 
γ phosphates; the A loop interacts with the purine ring of adenine; a Walker-B motif provides the 
catalytic glutamate; a signature LSGGQ motif (Walker C) orients ATP during hydrolysis; and D 
loop has a role in coupling hydrolysis to transport. A groove in the NBD surface forms the contact 
interface with the coupling helix of the TMD. These helices are the only architecturally conserved 
contact among distinct TMD folds and provide the majority of contacts between TMD and NBD4. 
 
In some cases, the basic structure is supplemented with additional membrane and 
cytoplasmic sections. Based on the TMD layout, ABC proteins can be divided into three 
structural families: Type I and Type II importers and exporters (Fig. 2). Prokaryotes have 
all three types of ABC proteins, while in eukaryotes – like in humans - only exporters 
occur (Fig. 2 red underline). In bacteria ABC pumps are generally involved in the uptake 




ions, etc.). In eukaryotes, most ABC proteins move compounds from the cytoplasm to the 
outside of the cell or into an intracellular compartment. Most human ABC proteins are 
active transporters, meaning they work against the electrochemical potential, to 
translocate substances. However, we also find an example of an ABC transporter acting 
as an ion channel (ABCC7/CFTR) or a regulator protein that defines the operation of 
other transporters (ABCC8)3,5,6. 
 
 
Figure 2. ABC-transporter structures. ABC importers TMDs are expressed as separate protein 
subunits that belong to either type I or type II. Yellow and green, TMDs; red, periplasmic 
substrate-binding proteins; purple and blue, NBDs. The TMDs and NBDs are fused in B-family 
exporters. In eukaryotes only exporters occur (red underline)4. 
 
Some ABC proteins exhibit a high degree of substrate specificity, while other ABC 
proteins can move a variety of significantly, even chemically different molecules (e.g. 
ABCB1)7. Presumably the functional difference is a consequence of the sequential 
variance of TMD, though the relationship between amino acid sequence and degree of 
specificity have not yet been fully understood6.  
Several ABC proteins are involved in detoxification (MDR1/ABCB1)8, endo- and 
xenobiotic protection, oxidative stress reduction (MRP1/ABCC1)9 Thus, ABC multidrug 
transporters are essential parts of an immune-like defense system, and their network is a 
major contributor to “chemoimmunity” in living organisms by transporting toxic 
molecules out of the cell10. They therefore can play a key role in development of 
multidrug resistance (MDR)11. MDR is a main cause of chemotherapy inefficacy. Some 
cancers exhibit significant primary resistance to cytostatic drugs, others acquire MDR 




further treatment ineffectual11–13. Other ABC proteins play an important role in the lipid 
metabolism (ABCA1, ABCB4, ABCB11) 14,15 but also in the MHC I-type antigen 
presentation (TAP1/ABCB2, TAP2/ABCB3)16 or the ionic balance of the epithelium 
(CFTR/ABCC7)17. Their mutation, malfunction, or potential deficiency is responsible for 
many diseases. 
 
1.1.2. ABCB subfamily 
In my doctoral research, I studied ABCB6, member of ABCB subfamily. Although 
results have been controversial in recent years, first studies identified ABCB6 as a 
mitochondrial transporter, importing an intermediate of heme synthesis into the 
mitochondrial lumen.  
The ABCB subfamily contains four full transporters and seven half transporters. 
ABCB1 (MDR1/Pgp) was the first cloned human ABC transporter. It confers multidrug 
resistance phenotype to cancer cells. It has critical function in the blood–brain barrier and 
the liver8. ABCB11 (BSEP) exports bile salts from hepatocytes across the canalicular 
membrane. As a phospholipid translocator ABCB4 (MDR3), facilitates the incorporation 
of phosphatidylcholine into bile, so both proteins are involved in the secretion of bile 
acids18. ABCB2 and ABCB3 (TAP) are half transporters that form a heterodimer to 
transport peptides into the endoplasmic reticulum, which are presented as antigens by the 
Class I HLA molecules16. ABCB9/TAPL is a half transporter and shuttle cytosolic 
polypeptides into the lumen of lysosomes. Phylogenetic analysis suggests that TAPL was 
the common ancestor of the TAP family. TAPL orthologues are also found in 
Caenorhabditis elegans and in Agnates, as well in plants. None of these organisms has 
an adaptive immune system. Therefore, a more general function of TAPL can be assumed 
throughout multi-cellular organisms19.  
The remaining three half-transporters ABCB7, ABCB8 and ABCB10 localize to 
the mitochondria, and are involved in iron metabolism and transport of Fe/S protein 
precursors20. It is known that all three mitochondrial transporters contain a targeting 
signal21. The gene coding ABCB7 protein is considered to be the orthologue of the atm1 
gene found in yeast. The protein is responsible for mitochondrial iron homeostasis and 
plays a role in the maturation of iron-sulfur clusters. Its mutation causes X-linked 




be used to make heme molecules. The partial loss of the function of ABCB7 directly or 
indirectly inhibits hem biosynthesis thereby causing decreased amount of hemoglobin or 
red blood cells (RBCs) in the blood22. ABCB8 performs similar tasks in the body. 
Additionally, mitochondrial iron accumulation has been observed in the study of abcb8-
deleted mouse myocardium tissue. Mitochondrial injury, increased levels of reactive 
oxygen radicals, and death of cells were also detectable. In vitro silencing of ABCB8 
decreased iron excretion from mitochondria and overexpression of the protein resulted in 
an opposite effect23. Studies in mice also revealed that higher levels of oxidative stress 
occurred in heterozygous animals after ischemic/reperfusion. The amount of reactive 
radicals and damaged lipids increased, resulting in reduced mitochondrial respiration. 
Like ABCB7, ABCB8 is also essential for cytosolic maturation of the iron-sulfur cluster, 
its deletion in vivo and in vitro led to decreased activity of iron-sulfur-containing enzymes 
in the cell plasma20. ABCB10 is also localized in the inner membrane of the mitochondria, 
forming homodimers with its NBD orienting towards the mitochondrial matrix. During 
erythroid maturation, the protein is produced in large yields, which increases the 
hemoglobin synthesis in erythroid cells. ABCB10 is expressed not only in erythroid 
tissues but also in many other tissues, suggesting that its function is not directly related 
to hemoglobin synthesis. Although the dysfunction of the mitochondrial ABC 
transporters described above results in relatively well-detectable phenotypes, the specific 




ABCB6 is a half ABC transporter of 842 amino acids, containing a unique N-
terminal region followed by the ABC-core consisting of a transmembrane domain and a 
cytoplasmic nucleotide binding domain24–26. ABCB6 forms homodimers and is widely 
expressed in many tissues, especially in the heart, liver, skeletal muscles27, red blood 
cells28,29, and skin30. The first publications identified the protein under different names 
(PRP, MTABC3, UMAT) but finally the transporter was officially named ABCB6, based 





1.2.1. Identification of a new protein 
Pgp (P-glycoprotein/ABCB1) is an ATP-dependent drug efflux pump for 
xenobiotic compounds with broad substrate specificity. It is responsible for decreased 
drug accumulation in multidrug-resistant cells and often mediates the development of 
resistance to anticancer drugs31. ABCB6 was identified in 1997 and based on sequential 
similarity, it was named P-glycoprotein related protein (PRP). The authors screened a 
normal rat liver cDNA library with probes corresponding to the coding sequence of the 
NBD of Pgp protein. This new transcript was detected in many normal tissues and was 
overexpressed in rat hepatocarcinoma cells. Already the first sequence analysis pointed 
out that ABCB6 may be related to Heavy Metal Transporter factor-1 (HMT-1). BLAST 
search of the non-redundant databases revealed that a cDNA isolated from 
Schizosaccharomyces pombe, encoding a heavy metal tolerance gene, was the most 
similar to PRP, with 61% similarity and 44% identity over the nucleic acid and amino 
acid sequence32. The first hypothesis about the physiological role of ABCB6 was based 
on Saccharomyces cerevisiae studies. To identify the human ortholog of mitochondrial 
yeast Atm1p, researchers screened the GenBank data base, and found two ABC proteins: 
the already known ABCB733 and ‘EST 45597’. Mitsuhashi and his colleagues showed 
that the transcript was expressed widely in rat tissues and in different cell lines. This new 
gene, named MTABC3 (mitochondrial ABC protein 3), encodes 842 amino acids of a 
protein that has 31.1% identity to Atm1p. The authors noticed that it has 47.5 and 42.9% 
similarity to Schizosaccharomyces pombe HMT-134 and human ABCB7, respectively. 
Based on this relation between ABCB6 and ABCB7, the authors hypothesized 
mitochondrial localization. For immunoblot and microscopic analysis, flag tagged 
MTABC3 was expressed in CHO cells. For functional analysis, an Atm1p-deficient S. 
cerevisiae strain was used that showed a 50-fold higher level of free iron accumulation 
then wild-type control cells. It was found that MTABC3 is mitochondrial and atm1p 
mutant cells can be rescued by the expression of MTABC3. The non-functional ABCB6 
mutant variant surprisingly effectively rescued the mutant phenotype27. 
Meantime another group also identified the protein and because it was expressed 
universally in all tissue UMAT (Ubiquitously expressed Mammalian ABC half-
Transporter) name was given to it. Using arsenic resistant hepatocarcinoma cells, the 




resistance-associated proteins (MRP1,2, or 3) or P-glycoprotein related protein (ABCB6) 
but alteration could not be detected35. 
As previously mentioned, Furuya and Schuetz identified rat Abcb6 in 199732, then 
they reported the isolation of the human ABCB6 gene in 200236. The protein was identical 
to the previously cloned MTABC3 human ABC transporter27. Emadi-Konjin and his 
colleagues found that ABCB6 was overexpressed in human hepatocellular carcinomas 
compared to surrounding non-malignant tissue (there was no difference in ABCB6 copy 
number between tissues). Screening a human liver genomic DNA library, a 14 kb 
genomic DNA fragment was isolated which contained the ABCB6 gene. Using luciferase 
assay the promoter region was predicted on the forward strand of ABCB6 beginning 3565 
to 3315 bp from the translational start site. Based on bioinformatic analysis the 5’-
flanking region contains a CpG island and a number of putative transcription factor 
binding sites. The predicted ABCB6 promoter region is GC-rich and contains six 
glucocorticoid response (GR) elements, three putative c-myc binding sites within the CpG 
island. In spite of different expression levels between normal and cancer liver cells, the 
function of ABCB6 remained unknown36. 
 
1.2.2. ABCB6 and porphyrins 
In 2006, Krishnamurthy and colleagues established the classification of ABCB6 as 
mitochondrial transporter. In a seminal Nature article they claimed that ABCB6 imports 
porphyrins into the mitochondria25. Porphyrins are important intermediates of the highly 
conserved heme synthesis pathway. In humans, during erythroid maturation, cells have a 
high demand of heme molecules to produce hemoglobin. In other species, the pathway 
also produces similar substances such as cobalamin (vitamin B12). The heme synthesis 
starts and ends in the mitochondrial matrix, but the intermediate steps occur in the cytosol. 
The initial molecules are glycine and succinyl-CoA, they form δ-aminolevulinic acid 
(ALA) by ALA synthase, which is strictly regulated by intracellular iron levels and heme 
concentration. ALA is transformed into porphobilinogen in the cytoplasm, and four 
molecules of porphobilinogen form a linear tetrapyrrole, which is closed by enzymatic 
processes. The coproporphyrinogen III molecule (CPgenIII) enters the mitochondria and 
protoporphyrin IX (PPIX) is formed by oxidation steps. The closing step is made by 




mitochondrial matrix (Fig 3). The heme synthetic pathway can be upregulated by ALA 
treatment and blocked by succinyl-acetone (SA)37. In 2006 Krishnamurthy and his 
colleagues observed elevated ABCB6 expression in human and murine fetal livers, which 
became upregulated during erythroid maturation. Treatment of MEL (myeloid erythroid 
leukemia) cells with ALA to induce heme biosynthesis caused a dose- and time-
dependent increase in ABCB6 protein and mRNA levels. In contrast, blocking heme 
synthesis pathway by SA led to decreased intracellular PPIX levels and ABCB6 
expression. Results from immunoblot and confocal microscopy experiments suggested 
that Flag-tagged ABCB6 is localized to the outer membrane of mitochondria. Using 
hemin-agarose affinity chromatography it was concluded that ABCB6 is a hemin binding 
protein and beside heme it could bind CPIII and PPIX molecules. Using isolated 
mitochondria, the ATPase activity of the ABCB6 protein seemed to be stimulated by 
CPIII. The authors found that PPIX fluorescence values were much greater in ABCB6-
overexpressing K562, Saos-2 and MEL cells than in vector-control or ABCB6 non-
functional mutant variant expressing cells (ABCB6-K629M). Every result therefore 
suggested that ABCB6 is located in the outer membrane of the mitochondria and it 
imports coproporphyrinogen III, thus acting as a main factor of heme biosynthesis25,38. 
Overexpression of ABCB6 significantly increased intracellular (but not 
intramitochondrial) heme concentrations in K562 myeloid leukemia cells. ABCB6 
overexpression also positively influenced expression and activity of hemoproteins, 
catalase and cytochrome c oxidase. It was suggested that ABCB6 plays a primary role in 
regulating hemoproteins by modulating intracellular heme concentration. Interestingly it 








Figure 3. The putative role of ABCB6 in heme synthesis. The initial step is the condensation 
of a succinyl coenzyme-A and glycine molecule, resulting in the formation of δ-aminolevulinic 
acid in the mitochondrial matrix. The synthesis continues in the cytosol, where four molecules of 
porphobilinogen form a linear tetrapyrrole. This linear molecule is closed by enzymatic processes 
then protoporphyrin is produced by oxidation steps, to which the ferrochelatase enzyme 
incorporates the divalent iron ion. The putative role of ABCB6 in this pathway is the 
mitochondrial porphyrin uptake. 
 
 
1.2.3. ABCB6 and resistance 
Other early studies took a different approach and suggested that ABCB6 may be 
involved in multidrug resistance (MDR). It was found that increased ABCB6 expression 
correlated with different cancer types. Increased resistance was observed against 




and paclitaxel/FEC (5-fluorouracil, epirubicin and cyclophosphamide) in breast cancer 
cells41. Expression levels of 45 genes from the ABC superfamily were analyzed in 
different drug resistant (doxorubicin/methotrexate/topotecan/paclitaxel/vincristine) 
ovarian carcinoma cell lines. Three transporters were significantly upregulated: ABCB1, 
ABCB4 and ABCG2. ABCA8 gene was significantly downregulated. ABCB6 was 
slightly upregulated in every cell line and paclitaxel caused the biggest deviation in 
expression levels42. In 2007 an article was published in which high ABCB6 mRNA 
expression level was found in primary melanoma and also in metastatic melanoma cells43. 
In 2009 an antioxidant response element was identified at –7575 base pair up-stream of 
the ABCB6 transcription site in human small airway epithelial cells44. Moreover, in 2011 
it was reported that ABCB6 protect cells from oxidative stress and conferred arsenite 
resistance to HepG2 and Hep3B hepatocellular carcinoma cells45. In another arsenite-
resistant cell line, in KAS myeloma cells ABCB6 overexpression enhanced resistance to 
5-fluorouracil (5-FU), SN-38 and vincristine (Vcr) but not to arsenite. However ATO 
(arsenic-trioxide) resistant human epidermoid carcinoma cell line had higher ABCB6 
expression level and accumulated less arsenic then parental cells46. The cellular 
differences between epidermoid and hepatocarcinoma cells may have led to different 
results47. 
ABCB6 was also connected to drug resistance but not in a chemotherapeutic 
perspective: Gómez and colleagues found that increased intracellular survival of 
Leishmania panamensis in human macrophages treated with antimonial drug correlates 
with low expression of the transporter ABCB6. It seemed that antimony could induce 
ABCB6 expression in human macrophages. Furthermore, the protein was detected in the 
cell membrane and the phagolysosomal membrane surrounding the intracellular 
pathogen. Based on these results the authors speculated that ABCB6 acts as an efflux 
pump in the cell membrane and as an importer when localized to intracellular 
membranes48. 
In the last few years several papers have been published about the diverse 
pharmacological relevance of ABCB6. A study showed that women younger than age 50 
had significantly higher levels of mRNA expression for several drug transporters, 
including ABCB649. Analyzing Taxol resistant cells, ABCB6 was identified as an 




expression levels of ABCB6, ABCC3 and ABCC10 can be valuable predictors of prostate 
cancer progression51. Strong correlation was also detected between ABCB6 expression 
levels and progression of human gliomas52. Another prostate cancer study showed 
elevated PPIX levels in dormant PC3 cells and upregulated ABCB6 expression53. 
Interestingly, in acute myeloid leukemia mRNA expression of ABCC3 and ABCB6 were 
significantly higher in daunorubicin resistant samples compared to sensitive ones54. 
Another observation occurred in D. melanogaster, where authors found that suppression 
of ABCB6 increased mortality when animals were treated with malathion insecticide55. 
Researchers hypothesized several times that ABCB6 can mediate protection against 
cytosolic ROS45,56–58. It was mentioned above that Hübner and his colleagues identified 
an antioxidant response element in ABCB6 promoter region examining epithelial cells44. 
Association between ABCB6 and resistance to these diverse therapeutic compounds 
required explanation. The putative protective mechanism was to eliminate ROS by 
producing more heme to increase catalase activity38. Catalase enzyme converts toxic 
hydrogen peroxide to water using heme as a co-factor. In the recent years three studies 
supposed positive correlation between ABCB6 expression level and smoking59–61. In the 
latest article an in vitro model of oral keratinocyte cell line was developed by exposing 
them with different concentrations of cigarette smoke extract (CSE). CSE treatment 
increased cytotoxicity and cell death through ROS generation in keratinocyte cells. 
Cigarette smoke exposure was associated with elevated ABCB6, while smoking cessation 
was associated with lower expression of ABCB6. In addition to toxic components, 
cadmium and arsenic can be found in tobacco products61. 
In 2018 another puzzling result emerged about the connection of ABCB6 and a 
parasite. It was observed that erythrocytes from Lan null individuals are resistant to 
invasion by Plasmodium falciparum parasites. Cells from six unrelated donors with null 
alleles were examined and it was found that parasite invasion was impaired in all cases 
when ABCB6 was absent. But other Plasmodium species could invade Lan null 
erythrocytes, so this genetic background does not provide defense against all Plasmodium 
parasites. This suggests that P. falciparum may have special connection with ABCB6 as 
a host factor during invasion. Based on this observation, Lan null blood group can be 





1.2.4. ABCB6 – contrasting results on intracellular localization 
Contrary to the suggested mitochondrial function25, in 2007 researchers observed 
extramitochondrial localization of ABCB6. Paterson and co-workers found that two 
distinct molecular weight forms of ABCB6 protein exist in SNB-19, U251 glioblastoma 
and KB-3-1 epidermoid carcinoma cells. Using novel antibodies, it seemed that the low 
weight form (79 kDa) was located to the mitochondria while high weight form (104 kDa) 
was located to the plasma membrane of the cells63. Tsuchida and his colleagues suggested 
other extramitochondrial localization for ABCB6. It was found that the transporter is 
located mainly in the Golgi system, and they presented confocal pictures of Cos-7 cells 
and proposed that the N-terminal extension of ABCB6 acts as an ER-targeting signal 
owing to its special hydrophobic nature64. A human colon adenocarcinoma line (LoVo) 
cell line was found devoid of endogenous ABCB6 mRNA. LoVo cells were used for 
heterologous expression of rat Abcb6. Performed distinct methods (subcellular 
fractionation, indirect immunofluorescence analyses, and determination of fluorescent 
rAbcb6-GFP distribution) authors concluded that rAbcb6 was localized to endolysosomal 
structures. Primary rat hepatocytes and liver tissue sections also corroborated this 
intracellular localization. Moreover, expression of rAbcb6 in LoVo cells increased the 
tolerance toward copper. The authors suggested that rAbcb6 may play a role in transition 
metal homeostasis56. 
In our laboratory during her PhD work, Katalin Kiss tried to prove the mitochondrial 
localization of ABCB6. It was difficult to reconcile mitochondrial localization with 
studies suggesting that ABCB6 may play a role in increased resistance to 
chemotherapeutic agents in tumor cells. After years of thorough work our results24 
questioned the reigning concept linking ABCB6 to mitochondrial porphyrin import25,65. 
During the study more approaches were used, first, we examined the intracellular location 
of ABCB6 in K562 human erythroleukemia and in HeLa cells. Intracellular organelles 
were separated from HeLa cells by differential centrifugation. Different membrane 
fractions were analyzed by immunoblot to characterize the localization of endogenous 
ABCB6. Because mitochondrial contamination was detected in the fractions, in further 
experiments, immunomagnetic separation was used. With the organelle markers we 
proved that lysosomes are devoid of mitochondrial contamination. The experiments 




absent from the mitochondrial fractions. In the next step, it was shown that ABCB6 is 
expressed in human erythrocytes. The glycosylation of the protein was studied on 
erythrocyte ghosts. Glycosidase treatment resulted in a marked shift in molecular weight 
of the protein. This meant that B6 was indeed produced in the N-glycosylated form and 
was located to the plasma membrane of mature erythrocytes. Note, that mature red blood 
cells no longer contain other membrane structures (intracellular organelles), including 
mitochondria. Fukuda and his colleagues also observed that the protein undergoes 
glycosylation in the cells66. This posttranslational modification is predominantly specific 
for proteins in the plasma membrane and the endolysosomal continuum. The hypothesis 
proposed by the laboratory of J. Schuetz suggested that ABCB6 caused elevated 
mitochondrial uptake of porphyrin which led increased PPIX fluorescence in the cells. 
The following experiments showed that however the level of ABCB6 increased during 
erythroid maturation of K562 cells, the attenuation of ABCB6 did not affect hemoglobin 
synthesis or erythroid maturation of the cells. We concluded that ABCB6 is not required 
for the synthesis of porphyrins. Fluorescently labeled ABCB6 was expressed and 
analyzed by confocal microscopy in K562 and HeLa cells. Results showed that 
endogenous protein clearly colocalized with lysosomal markers, which were in line with 
data from membrane fractionation. These results fundamentally call into question the 
mitochondrial localization and the role of ABCB6 in heme biosynthesis.24. 
 
1.2.5. Structure – Function relation  
Although ABCB6 was thought to be a mitochondrial protein, it is important to note 
that it does not contain a target signal like the other mtABCs24. Generally, the 
mitochondrial targeting signal is a 10-70 amino acid sequence forming an amphipathic 
helix at the N-terminal. Cleavable pre-sequences are the classical type of mitochondrial 
targeting signals. However, numerous types of non-cleavable targeting and sorting 
signals, which are located in the mature regions of mitochondrial proteins, have also been 
described21. Half-transporters in the B subfamily contain additional, relatively long and 
unique sequences, which have been implicated in protein–protein interactions and 
targeting. Topology prediction programs for transmembrane proteins (i.e., CCTOP, or 
HMMTOP) suggested that ABCB6 contains 11 transmembrane (TM) helices, of which 




(TMD0) does not show sequence homology to any other protein. Kiss investigated the 
function of the TMD0 domain and created N-terminal truncated variants of ABCB6 in 
Sf9 (Spodoptera frugiperda) model cell lines. The expression level of ABCB6-core in 
Sf9 insect cells was comparable to full-length ABCB6, suggesting that it could fold 
properly and integrate into the membrane. After checking the expression of the truncated 
protein, functional assays were performed. Being an ABC transporter, ABCB6 cleaves 
ATP generating ADP and inorganic phosphate (Pi) which is linked to substrate 
translocation. This can be tested in an ATPase assay where Pi can be measured by a 
simple colorimetric reaction. The amount of released Pi is directly proportional to the 
activity of the transporter and transported substrates can increase baseline ATPase 
activity. On Sf9 vesicles containing ABCB6, basal or substrate-stimulated ATPase 
activity could not be detected. However, implementing azido-ATP and trapping assays, 
we showed that ABCB6-core variant was able to bind ATP and cleave the bound ATP 
molecule. The non-functional K629M mutant allowed ATP binding, but prevented ATP 
hydrolysis. For further experiments, ABCB6 protein variants were successfully expressed 
in human cell lines (HeLa and K562). Co-immunoprecipitation assay revealed that the 
TMD0 is not required for protein dimerization but it contains a glycosylation site
67. This 
predicted glycosylation site was in agreement with the literature66. In the next step 
intracellular localization of the truncated variant was examined by confocal microscopy. 
While the wild-type protein co-localized with lysosomal markers, ABCB6-core variant 
was detected in the plasma membrane. In contrast, the TMD0 fragment showed lysosomal 
localization similar to the wild-type protein. These results suggested that the N-terminal 
extension of the transporter is an independent folding domain with sufficient information 
for lysosomal targeting (Fig. 4). Electron microscopy analysis showed that ABCB6 was 
localized to the membranes of multivesicular bodies, multilamellar lysosomes and dense 
lysosomes67. Fukuda and co-workers studied intramolecular disulfide bonds and 
glycosylation of ABCB6. They showed that during maturation, ABCB6 is glycosylated 
at a conserved single atypical amino-terminal site (Cys-8). Results showed that mutation 
of highly conserved cysteines destroyed the disulfide bonds, leading ER retention of the 
protein. The data suggested that these cysteines are important for proper folding and 






Figure 4. Intracellular targeting of GFP-tagged ABCB6 variants in HeLa cells. Cells were 
transfected by GFP-fusion proteins. Localization of ABCB6–GFP, core–ABCB6–GFP and 
TMD0–GFP was revealed by GFP (green) in the context of the lysosomal marker LysoTracker 
(red)67. 
 
In case of transporters a functional assay greatly facilitates the examination of the 
structure-function relation. Chavan and his colleagues developed an in vitro system with 
pure and active protein, where they could investigate the function of ABCB6. In the first 
step of the essay, the FLAG tagged protein was overexpressed in HEK293 cells. The 
tagged ABCB6 was purified from the mitochondrial fraction of the cells. In binding assay, 
they saw that ABCB6 retained its ability to bind ATP through the purification process. In 
ATPase assay the non-functional mutant (ABCB6-K629M) showed only background 
activity, while the purified ABCB6 was active in ATP hydrolysis. To analyze ABCB6 in 
its membrane-embedded state, purified mitochondrial ABCB6 (both WT and K629M) 
was reconstituted into preformed detergent-destabilized liposomes. Performing hemin-
agarose affinity chromatography authors found that CPIII was able to displace liposome-




lipid-reconstituted ABCB6 demonstrated basal ATPase activity that was comparable to 
the ATPase activity of the purified detergent-solubilized protein. Activity was strongly 
stimulated in the presence of CPIII, hemin, and protoporphyrin IX. CPIII uptake of WT-
ABCB6 and transport incompetent ABCB6-KM liposomes were also measured, which 
authors concluded as an ATP-dependent substrate transport of ABCB626. 
 
1.2.6. ABCB6 knockout mice 
In spite of the putative essential mitochondrial porphyrin transport, Abcb6 knockout 
mice appeared phenotypically normal. However, evaluation of their hematological 
parameters revealed mild anemia. Phenylhydrazine (Phz) is a generally used molecule to 
induce acute hemolytic anemia in animal models. When Abcb6 KO mice were chemically 
stressed with Phz greater mortality and a more sustained anemia was observed. The 
authors concluded that ABCB6 is the sole mammalian ATP-dependent mitochondrial 
porphyrin importer, while they suggested that ABCB6 only mean benefit in stressful 
situations58. Next, Krishnamurthy and his co-workers also studied the physiological 
function of Abcb6 in knockout mice. It was found that deficiency of the protein in vivo 
does not have a significant impact on basal hepatic porphyrin or heme levels. Based on 
earlier results of the research group68 cytochrome P450 oxygenase (CYP) enzymes were 
investigated in Abcb6+/+ and Abcb6-/- mice. CYPs are hemoproteins, they use heme 
molecule as a cofactor. Mammalian hepatic CYPs are involved in the metabolism of 
endogenous compounds and xenobiotics69. Abcb6−/− liver microsomes showed 
significant decrease in midazolam biotransformation, suggesting decreased Cyp3a11 
activity in Abcb6 KO mice. Several CYP enzymes were tested and results showed that 
Abcb6 deficiency in mice modified the activity of a specific set of hepatic P450s. 
Measuring mRNA and protein levels of CYPs, it was found that altered P450 activity in 
Abcb6−/− mice is due to decreased expression of P450s. Though Abcb6−/− mice did not 
show any observable gross or histological alteration in liver, nor did they demonstrate 
any increase in serum biomarkers of liver injury. ABCB6 was attenuated in human 
hepatoma cell lines (Hep3B and Huh7) and expression of CYPs were monitored. Results 
showed decreased level of CYP1A2, CYP2B6, and CYP3A4 transcript. After accurate 
experiments with CYP enzymes authors concluded that ABCB6 deficiency could involve 





1.2.7. ABCB6 and pathology 
In each specific porphyria the activity of specific enzymes in the heme biosynthetic 
pathway is defective. Porphyrias may also be classified as either erythropoietic or hepatic, 
depending on the principal site of accumulation of pathway intermediates71. In 2016 it 
was found that severely affected porphyria patients were heterozygous for ABCB6 
alleles. In experiments using a mouse model, genetic deficiency of ABCB6 coupled with 
a Fech deficiency (a classic porphyria model) produced greater porphyrin elevation in red 
blood cells, hepatocytes, and increased liver damage72. Despite these results, in the well-
controlled laboratory environment, Abcb6 KO mice have no pathological phenotype70. 
While researchers were hunting for a connection between ABCB6 and drug resistance45,58 
or cell cycle regulatory components that are involved in carcinogenesis73,74, the first 
disease linked to a mutation in the ABCB6 gene was described. In ocular coloboma, which 
is an eye development disorder, two missense mutations were identified (L811V and 
A57T) in ABCB6 in Chinese population. Comparative analyses of ABCB6 genes in 
different species showed that both amino acids are highly conserved, presumably 
essential to normal biological function. In RPE cells wild type and L811V mutant ABCB6 
showed colocalization with ER and Golgi markers. ABCB6 attenuation by morpholino 
oligos caused coloboma-like phenotype in zebra fish. Normal phenotype could be 
restored by the co-injection of wild type, but not by the mutant ABCB6 mRNA. In these 
experiments there was no detectable porphyrin accumulation that would suggest a role 
for ABCB6 in tetrapyrrole transport75. 
The Langereis (Lan) blood group was first described in 196176 but scientists 
identified ABCB6 as the Lan blood group antigen only in 2012. First monoclonal 
antibody with Lan specificity (OSK43; IgG1κ) was generated from immortalized 
lymphocytes of a healthy Japanese Lan (-) woman who had developed anti-Lan antibody 
during pregnancy. This antibody proved that the protein is located at plasma membrane 
of RBC (which are devoid of mitochondria) and also hepatocellular carcinoma cells. 10 
patients bearing ABCB6 null mutations were analyzed and they seemed asymptomatic, 
they did not show anemia or abnormal erythropoiesis28. Lan-negativity is believed to be 
very rare77,78 but recent population and genetic studies show that missense 




While reports published continuously about porphyrin transport68,79,52 other 
clinically important mutations of ABCB6 appeared in the literature30,30,80–82. Genetic 
studies reveal that mutations in ABCB6 can cause two other phenotypes, familial 
pseudohyperkalemia (FP)81 and dyschromatosis universalis hereditaria (DUH)83. FP is a 
dominant red cell trait characterized by increased serum potassium concentration in 
whole blood stored below room temperature, without additional hematological 
abnormalities. DUH is a pigmentary genodermatosis characterized by a mixture of 
hyperpigmented and hypopigmented macules distributed randomly over the body. I shall 
return to this in more detail below. Through the years new heterozygous mutations were 
described: healthy Lan (-) individuals84,85,86, DUH87 88–91, FP92,93 and coloboma patients94. 
We are not aware yet of the factor when ABCB6 protein expression provides 
obvious benefits to a cell or organism but it is clear that mutations in the ABCB6 gene can 

























1.2.8. ABCB6 and cadmium 
Observation that ABCB6 exhibits topological and sequential similarities with a 
heavy metal transporter protein family has appeared earlier in several places in the 
literature32,65,95.  
Detoxification capacity of organisms is extremely important, as heavy metals such 
as cadmium (Cd), mercury (Hg), lead (Pb), and arsenic (As), are constantly present in our 
environment. Contamination in the drinking water and food can cause serious damage to 
living organisms. Research summarizing statistical data suggests that the risk of 
developing cancer can increase in areas exposed to high Cd levels96. By using chelators, 
the intracellular concentration of free metal ions can be reduced, thereby lower their toxic 
effect. The natural defense is based on similar principle, meaning animals and fungi 
produce cysteine-rich proteins that bind heavy metals to form thiolate bonds97. On the 
other hand, plants and certain species of fungi, (i.e. Schizosaccharomyces pombe) 
produce small peptides, phytochelatins (PCs). Caenorhabditis elegans, which is an 
exception in the animal kingdom also use PCs in its detoxification pathways. PCs are 
characterized by the repetition of glutamic acid-cysteine amino acid residues followed by 
glycine. The formation is catalyzed by phytochelatin synthase (PCS) from 
glutathione98,99. Importance of PCs is proven by the fact that PCS-deleted fission yeast 
(S. pombe) strains become more sensitive to heavy metals100. After finding PC-mediated 
Cd tolerance, the goal was to identify the proteins involved in the transport process. As a 
first step, the genomic library of S. pombe was created, and then a coding region was 
identified, which could restore the Cd-tolerant phenotype. The identified gene was named 
Heavy metal tolerance factor-1 (hmt-1). The gene is located on chromosome 3 and it 
encodes a protein containing 830 amino acids with a molecular weight of 90.5 kDa. 
Homologues were identified in fission yeast (Schizosaccharomyces pombe), nematode 
(Caenorhabditis elegans) and the fruit fly (Drosophila melanogaster) fulfill a conserved 
role in conferring resistance to heavy metals, specially cadmium34,101. 
In S. pombe HMT-1 localizes to the vacuolar membrane and catalyzes the 
sequestration of cadmium complexes to this intracellular compartment102. Experiments 
with C. elegans surprisingly revealed that, unlike SpHMT-1, CeHMT1 is able to provide 
tolerance to cadmium, arsenic and copper as well. The Vatamaniuk Lab showed that 




cells103,104. In 2018 they identified the intracellular localization of CeHMT-1 in the 
intestinal cells. The transporter is located to the apical recycling endosomes and partly to 
early and late endosomes. Similar to ABCB667, CeHMT-1 lacking the NTE domain was 
targeted to the plasma membrane95. A deficiency in Ce-HMT-1 does not interfere with 
the phenotype associated with CePCS-1 deficiency and vice versa. It became clear that 
HMT1-deficient worms are more sensitive to Cd than PCS-deficient ones. It was 
concluded that although CeHMT-1 is required for Cd detoxification, it is not only PC-
dependent105. This is important because, following the evolution of HMT-1, neither D. 
melanogaster cells nor the human cells carry out the detoxification of heavy metals by 
conjugation with phytochelatins. Since D. melanogaster is devoid of PCs, further 
experiments were needed to determine whether Cd-PC complex is transported in yeast 
cells. Heterologously expressed DmHMT-1 suppressed the Cd hypersensitivity of S. 
pombe hmt-1 mutants and localized to the vacuolar membrane. Despite this the vacuolar 
level of PCs were similar to the vacuoles from hmt-1-deleted cells. The authors assumed 
that SpHMT-1 is not the only Cd-PC carrier in the system. Several heavy metals were 
also tested in this rescue system. PCS-deficient S. pombe cells were hypersensitive to Cd, 
Hg and As, but SpHMT-1 does not cause tolerance to additional (heavy) metals Pb, Ag, 
As(III), Cu or Hg101. Experiments with C. elegans have revealed that, unlike SpHMT-1, 
CeHMT-1 can provide tolerance to cadmium, arsenic and copper106. These results 
indicated that the HMT-1-mediated detoxification of heavy metals is preserved during 
evolution, extending to some invertebrate species lacking the ability to synthesize PC101.  
 
1.2.9. ABCB6 and pigmentation 
Dyschromatosis universalis hereditaria (DUH) is a pigmentary genodermatosis 
characterized by diffuse symmetrically distributed hypopigmented macules mixed with 
hyperpigmentation. The molecular basis of DUH was unknown until Zhang and his 
colleagues reported ABCB6 as a causative gene30. Since then, more mutations of ABCB6 
were identified relating to DUH phenotype30,83,87,88,91,107. Interesting fact, that Lan (-) 
individuals28 and ABCB6 knockout mice show no abnormal pigmentation phenotype70,72.  
Melanin is a natural pigment widespread in most organisms. Specialized pigment 
cells, including melanocytes and retinal pigment epithelium, synthesize melanin. 




melanin: eumelanin, pheomelanin, and neuromelanin. Eumelanin is generally black or 
dark brown, pheomelanin is a yellow to reddish brown pigment108. Both pigments are 
polymeric and are derived via a series of redox reactions from a common precursor, 
dopaquinone, which is formed by the action of the enzyme tyrosinase on Tyr residue. 
Pheomelanin synthesis starts from tyrosine and cystine and contains polybenzothiazine 
portions109,110. Melanosomes are specialized intracellular organelles of pigment cells in 
which melanin pigments are synthesized and stored. They are members of a family of 
cell-type-specific lysosome-related organelles (LROs) that coexist with traditional 
endosomes and lysosomes and are generated from them through a progressive series of 
membrane sorting steps87,111. Lysosomal-like organelles carry a number of common 
characteristics with lysosomes, while requiring special proteins, other additional 
elements, cellular organelles for their construction and function112,113. Lysosomes and 
LROs are involved in a number of processes, including cholesterol homeostasis, 
maintenance and repair of plasma membranes, bone and tissue regeneration, protection 
against pathogens, regulation of cell death and signaling processes (Fig. 6). There are four 
steps in the maturation of the melanosome (Fig. 7A). Melanosomes originate from 
endosomal precursors (pre-melanosomes). The best known of the structural components 
is the pre-melanosomal protein (PMEL), which is a fibrillar component of melanosomes. 
 
Figure 6. Biogenesis of lysosomes and lysosome-related organelles (LROs) 
(https://mynotebook.labarchives.com) LROs comprise a group of functionally diverse 
compartments that share features with lysosomes but are distinct and harbor specific cargoes that 
confer their unique properties. There are four well-studied LROs: pigment cell melanosomes, 





PMEL is processed into amyloid fibrils forming the intraluminal matrix of stage II 
melanosomes. PMEL-derived amyloid structures belong to the emerging category of 
physiological amyloids that have beneficial cellular functions115. During maturation, 
PMEL is cleaved by several proteases to release luminal amyloidogenic fragments116–118 
(Fig 7). After translation, the full length peptide chain reaches the endosomal membrane 
where β-site APP-cleaving enzyme 2 (BACE2) generates the transmembrane M-β 
fragment118. This C-terminal polypeptide is processed by the gamma-secretase complex 
containing presenillin-2 in the lysosomes of pigment cells119. BACE2-mediated cleavage 
releases the M-α fragment, the amyloidogenic luminal domain of PMEL, into the 
melanosome lumen118. The M-α fragment is proteolytically processed to produce the 
amyloidogenic peptides that finally assemble into detergent insoluble protofibrils and 
fibrils recognized by the HMB45 and NKI-beteb antibodies (Fig. 7B,C)116. Melanin starts 
to be produced in stage III melanosomes by Tyrosinase (TRP-1) and stage IV 
melanosomes correspond to fully-melanized mature organelles. At the final step, 
melanin-filled, mature melanosomes enter the extracellular space, similar to exosomes 
and are passed on to the keratinocytes around the pigment cell. Stage I melanosomes are 
tyrosinase negative, whereas stage II melanosomes, including fibrillary elongated 





Figure 7. Schematic picture of PMEL isoforms melanosomes and in different 
compartments. A Biogenesis of melanosomes. Stage I melanosomes, where PMEL fibrils start 
to assemble. In stage II melanosomes, PMEL fibrils give the melanosomes their characteristic 
ellipsoidal shape and striated appearance. Melanin starts to be produced in stage III melanosomes, 
to which melanin synthesizing enzymes, such as Tyrosinase (TRP-1), are transported. Melanin is 
sequestered on PMEL fibrils, which become completely masked by melanin in stage IV 
melanosomes. B Schematic representation of pre-melanosomal protein (PMEL) domain structure. 
Triangles, pentagons and rhombuses represent N- and O-linked glycosylation. PMEL cleavage 
sites and the involved proteases are indicated in red. C Model for pre-melanosomal protein 
(PMEL) fibril formation in stage I melanosomes. The Mα fragment of PMEL is released into the 
lumen of stage I melanosomes by action of BACE2 (beta-site APP cleaving enzyme 2) protease. 
This cleavage also produces a C-Terminal Fragment (CTF) that is sequestered at the limiting 
membrane of stage I melanosomes by the endosomal sorting complexes required for transport 
(ESCRT) machinery, to be further cleaved by the presenilin 2 (PSEN2) of the γ-secretase complex 
in lysosomes. The Mα fragment is then loaded onto intraluminal vesicles (ILVs). ILVs have been 
proposed to act as nucleators for PMEL fibril formation115. 
 
Amyloid PMEL fragments can be cytotoxic, so mutations distracting PMEL trafficking 
or processing can be associated with melanocyte survival or melanin defects115,117,122. 




Whereas melanosomes and lysosomes are distinct organelles in melanocytes124, recent 
studies have proposed that lysosomes are required for correct PMEL amyloid matrix 
formation125–127, suggesting a potential role for lysosomal proteins such as ABCB6 in 
early steps of melanosome biogenesis. 
Genetic pigmentation disorders give new insights into the understanding of the 
pigmentation process, including melanosome biogenesis, melanin synthesis111. Mutations 
in the ABCB6 gene manifest in DUH, which is characterized by hyper- and 
hypopigmented areas over the body. Skin histological examination of a DUH proband 
showed a normal number of melanocytes in the basal layer in both hyper- and hypo 
pigmented areas. However, the number of mature melanosomes in normal control and 
hyperpigmented skin areas was considerably higher than in hypopigmented area. 
Additionally, many immature melanosomes were observed in hypopigmented skin 
region. However, the influence of ABCB6 on the above described process of 
melanogenesis is not known and its intracellular localization and function are also not 
clear.  
We can see that conflicting observations were described about ABCB6 in the last 
two decades. Based on healthy Lan (-) patients, healthy ABCB6-KO mice and studies 
about the extramitochondrial localization we supposed that the protein is not an essential 
mitochondrial porphyrin importer. In summary, the pathophysiological function of 
ABCB6 in the endo-lysosomal continuum remains to be clarified. Therefore, we thought 







ABCB6 is usually discussed in the context of mitochondrial ABC transporters 
based on early studies suggesting that it catalyzes the mitochondrial import of a heme 
synthesis intermediate. Recent studies have evidenced alternative localizations, but the 
physiological function of ABCB6 in these extramitochondrial compartments has 
remained elusive. My overall aim was to establish in vitro assays for the study of the 
function and intracellular localization of ABCB6. ABCB6 shows high amino acid 
sequence similarity to HMT-1, which is involved in the heavy metal tolerance of 
Schizosaccharomyces pombe, Caenorhabditis elegans and Drosophila melanogaster. 
HMT-1 (heavy metal tolerance factor-1) localizes to the vacuolar/endosomal membrane 
of S. pombe and C. elegans where it catalyzes the sequestration of cadmium complexes. 
To analyze the relation of ABCB6 function to the HMT-1 proteins, I pursued the 
following aims: 
1. Investigation of the localization of heterologously expressed human ABCB6 in S. 
pombe and C. elegans.  
2. Pending successful expression in these model systems, the second aim was to 
analyze the function of ABCB6 in wild-type and knock-out strains.  
3. Relevance of Cd detoxification in human cells 
 
An additional aim was to use cellular models to decipher the role of ABCB6 in 
melanogenesis, and to suggest a functional model explaining the DUH phenotype.  
4. The third aim was to set up an in vitro model system to study the localization of 
ABCB6 in a melanocytic cell line.  
5. Given the link of ABCB6 mutation to aberrant pigmentation, the final aim was to 
set up an in vitro model system to characterize the role of ABCB6 variants 







3.1. Cell culturing 
S. pombe culture conditions and strains — The S. pombe strains BG_00008 (ade6-
M216, ura4-D18, leu1-32) and the hmt1-deleted mutant strain BG_H4691 (ade6-M216, 
ura4-D18, leu1-32) were a kind gift from R. Lill (Philipps-Universität Marburg). A 
common feature of these laboratory strains is adenine, uracil and leucine autotrophy. 
EMM Broth, EMM agar and EMM without dextrose were purchased from Formedium 
(Hunstanton, UK). Depending on the experiment, medium was supplemented with 225 
mg/l adenine-HCl, 225 mg/l L-leucine and 225 mg/l uracil. 
C. elegans culture conditions and strains — C. elegans experiments were performed 
together with János Barna and Dániel Kovács (Department of Genetics, Eötvös Loránd 
University). The strains were grown on solid Nematode Growth Medium (NGM) at 20 
°C containing a lawn of the bacterium Escherichia coli OP50128. The following strains 
were used: N2 C. elegans wild-type, var. Bristol; DP38 unc-119(ed3)III; VC287 hmt-
1(gk161)III; VF31 gfIs1[phmt-1::hmt-1::gfp, unc-119(+); VF12 hmt-1(gk161)III; 
gfIs1[phmt-1::hmt-1::GFP, unc-119(+)]. For microscopic studies we used the following 
strains (generous gift from Dr. Xiaochen Wang (Institute of Biophysics, Chinese 
Academy of Sciences)): XW1957: qxIs110 (pges-1::mCHERRY::RAB-5); XW1962: 
qxIs111 (pges-1::mCHERRY::RAB-7); XW9119: qxIs213 (pges-1::mCHERRY::RAB-
10). 
Cell lines — HeLa cells were purchased from ATCC, the glioblastoma SNB-19 cells 
were from DSMZ (Germany), and the melanoma MNT-1 cell line was a kind gift of 
Guillaume van Neil. HeLa and SNB-19 cells were grown in high glucose DMEM (Gibco 
521000-47) supplemented with 10% FBS, 2 mmol/l glutamine, and 100 units/ml 
penicillin and streptomycin (Life Technologies) at 37 °C in 5% CO2. MNT-1 cells were 
grown in DMEM high glucose medium (4.5 mg/ml Gibco, Grand Island, NY, USA) 
supplemented with 10% v/v AIM-V, 20% v/v FBS, 1% v/v sodium pyruvate, 1% v/v non-
essential amino acids, 100 U/ml penicillin and 100 μg/ml streptomycin. MNT-1 cells 
were incubated at 37 °C with 5% CO2 and regularly passaged at a density of 80% (1:8 
ratio). Cells were periodically tested for mycoplasma contamination with the MycoAlert 




3.2. Molecular cloning of ABCB6 and HMT-1 constructs 
Plasmid constructs were amplified in E. coli strain Top10 (Invitrogen, Carlsbad, CA, 
USA), grown at 37 °C in liquid Luria-Bertani (LB) medium supplemented with 
appropriate antibiotics. 
S. pombe — The hemagglutinin-tagged S. pombe hmt-1 cDNA (Z14055) was 
ordered from GenScript (Piscataway, NJ, USA). Human ABCB6 (NM_005689) cDNA 
was provided by Jill Paterson in pcDNA3.1-Flag vector63. My former colleague, Katalin 
Kiss generated the Walker-A region lysine mutant ABCB6 variant (K629M) by overlap 
extension PCR mutagenesis24. Melinda Gera generated various mutants of ABCB6 (Table 
S1). Hmt-1 and ABCB6 variants encoding cDNAs were subcloned into the pREP1 fission 
yeast expression vector. pEGFP-N1 (BD Biosciences, Franklin Lakes, NJ, USA) plasmid 
was used for the N-terminal GFP-tagging of the transporters by exchanging the ABCB6-
GFP construct from a respective pAcUW plasmid129 HMT-1-GFP was assembled by PCR 
(Polymerase Chain Reaction) using a primer pair generating a new restriction site at the 
3’end of the cDNA. First, HMT-1 C-terminal was cloned to pEGFP-N1, then the pREP1-
HMT-1-GFP expression plasmid was created by exchanging the C-terminal region of 
HMT-1. 
C. elegans — For experiments in C. elegans, codon-optimized ABCB6 cDNA was 
synthetized by GenScritpt (Piscataway, NJ, USA). To generate the phmt-1::ABCB6::gfp 
and phmt-1::ABCB6::mCherry reporter for localization studies, ABCB6 was subcloned 
in frame with the GFP sequence of the pPD95.75-GFP vector. The 5’ regulatory region 
of hmt-1 (2.8 kb immediately upstream of the start of the hmt-1 coding sequence) was 
PCR-amplified using primer pairs as previously104 and with another primer pair we 
introduced the appropriate restriction enzyme recognition sites at the 5′ and 3′ends (Table 
S1). The PCR-amplified hmt-1 promoter was subcloned into the pPD95.75-ABCB6-GFP 
vector. In the case of phmt-1::ABCB6::mCherry, the GFP reporter sequence of pPD95.75-
ABCB6-EGFP was changed to the sequence encoding mCherry from plasmid pRH21. 
Human cell lines — The lysine mutant ABCB6 variant of the Walker-A region 
(K629M) and DUH mutation G579E83 were generated by overlap extension PCR 
mutagenesis24,130. Constructs were cloned into lentiviral plasmid obtained via the 





3.3. Generation of transgenic lines 
S. pombe transgenic strains — Transformation of fission yeast cells was 
performed by Clontech Yeastmaker™ protocol131. Cells were grown to the appropriate 
density (A600nm of 0.5) in 50 ml of low glucose EMM medium (5 g/L glucose and adenine, 
leucine, uracil) then pelleted and washed with 50 ml of sterile water (700 g, 5 min) and 
suspended in 1 ml water. Cells were then washed with 1 ml of LiAc-TE (1.1 ml 10x TE, 
1.1 ml of 1 M LiAc 7.8 ml water) (700 g, 5 minutes). The pellet was resuspended in 250 
µl LiAc-TE (2x109 cells/ml). To 100 μl cell suspension, 2 μl of 10 mg/ml carrier DNA 
was added. 1.5 µg of DNA was added to the cells, and the mixture was incubated for 10 
min at room temperature then 50 min at 30 °C. Thereafter, 43 µl preheated (40 °C) of 
DMSO was added, and cells were heat-shocked (42 °C, 5 min). The transformed yeast 
was washed with 1 ml water (700 g, 5 min), and cells were plated in 100 μl water on 
EMM plate. EMM Broth and EMM Agar products were used for the growth of 
transformed cells, which were supplemented with adenine and uracil (225 mg/L), because 
S. pombe transformants were selected for leucine prototrophy (LEU2 gene is encoded on 
pREP1 expression plasmid). 
C. elegans transgenic strains — Applying Biolistic PDS-1000/He particle delivery 
system (BioRad, Hercules, CA, USA) transgenic strains were generated according to 
standard protocol by J. Barna and D. Kovács. 50 µl of a 60 mg/mL gold grain was coupled 
with 10-10 µg of pre-linearized ABCB6:GFP or ABCB6::mCherry construct or co-
transformation marker (unc-119(+)). Transgenic animals can be easily identified on 
immobile Unc phenotype background, because the wild allele of the co-transformed unc-
119 gene rescues the motionless unc-119(ed3) mutant adult hermaphrodites. Non-Unc 
transgenic animals exhibiting GFP or mCherry-mediated fluorescence were selected, and 
the stable integrated strains TTV634: eluIs310 [phmt-1::ABCB6::gfp + unc-119(+)]; 
unc-119(ed3) and TTV677: eluEx383[phmt-1::ABCB6::mCherry + unc-119(+)]; unc-
119(ed3) carrying the array extrachromosomally were selected for further analysis. TTV 
634 was crossed with hmt-1(gk161) to generate TTV 635: hmt-1(gk161); eluIs310 [phmt-







Table 1. List of worm strains used in the publication132. 
Strains Relevant genotype Source/Reference 
N2  Wild-type var. Bristol Caenorhabditis Genetics 
Center (CGC) 
DP38  unc-119(ed3)III Caenorhabditis Genetics 
Center (CGC) 
VC287  hmt-1(gk161)II Caenorhabditis Genetics 
Center (CGC) 




Dr. Olena Vatamaniuk 
(Cornell University) 
XW1957 qxIs110 (pges-1::mCHERRY::RAB-5) Dr. Xiaochen Wang 
(Institute of Biophysics, 
CAS) 
XW1962 qxIs111 (pges-1::mCHERRY::RAB-7) Dr. Xiaochen Wang 
(Institute of Biophysics, 
CAS) 
XW9119: qxIs213 (pges-1::mCHERRY::RAB-10) Dr. Xiaochen Wang 
(Institute of Biophysics, 
CAS) 
TTV634 eluIs310 [phmt-1::ABCB6::gfp + unc-
119(+)]; unc-119(ed3) 
132 
TTV 635 hmt-1(gk161); eluIs310 [phmt-
1::ABCB6::gfp + unc-119(+)] 
132 





TTV702  unc-119(ed3)III; eluIs310[phmt-























Human cell lines with enhanced or silenced ABCB6 expression — Lentiviral 
expression plasmids were made by K. Kiss and the cell lines were generated by N. 
Kucsma as described previously24. To induce the expression of the shRNA constructs, 
IPTG (1 mM) was added to the cells for 6 days before additional treatments. 
Transduction of MNT-1 cells with ABCB6 variants was carried out by the 
laboratory of G. van Niel using lentiviral transduction. For downregulation of ABCB6 
cells were transfected with siRNA using oligofectamine (Invitrogen). siRNA 
transfections were performed twice at 48 h interval and experiments were performed 96 
h after the first siRNA transfection. Predesigned siRNA obtained from Qiagen. siRNA 
non-targeting control: 5’- AAT TCT CCG AAC GTG TCA CGT -3’, siRNA ABCB6#1 
(Cat no.SI00080353), siRNA ABCB6#2 (Cat no.SI00080360), siRNA ABCB6#3 (Cat 
no.SI00080374), siRNA ABCB6#4 (Cat no.SI00083731), siRNA ABCB6#5 (Cat 
no.SI00080873), siRNA ABCB6#6 (Cat no.SI00080880).  
 
3.4. Immunoblotting 
S. pombe — Heterologous expression of the transporters in the fission yeast strains 
was verified by Western blotting. Before the Lowry protein concentration measurements 
(OD=600), we had to disrupt the cell wall of yeast cells. Cells were collected at 3000 g 2 
min and diluted in 1 ml of sterile water. 150 µl of 1.85 M NaOH and 7.5% β-
mercaptoethanol were added and the cells were incubated for 10 minutes at RT. 150 µl 
of 50% TCA was added and the samples were centrifuged at 2000 g for 5 min. The protein 
extract was washed in sterile water and suspended in DB buffer. Samples were 
homogenized by sonication. 
Human cell lines — Immunoblotting of HeLa and SNB-19 cell line were 
performed according to standard protocols. In the case of MNT-1 cells a Triton X-soluble 
lysate was prepared in 20 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% TX-100, 1 mM 
EDTA, protease inhibitors. The Triton X-insoluble fraction was resuspended in 1% SDS, 
1% β-mercaptoethanol in PBS containing protease inhibitors, incubated for 10 min at RT 
and then heated for 10 min at 100 °C. Light and dense melanosomal fractions and 
exosome isolation were performed as already described121,133. Lysates, fractions and 
exosomes were incubated in sample buffer with or without 350 mM 2-mercapthethanol 




12%) Bis-Tris gels (Invitrogen) and transferred onto nitrocellulose membranes 
(Millipore). The membranes were blocked in PBS/Tween 0.1% (PBS/T) with 5% non-fat 
dried milk, incubated with the indicated primary antibody diluted in PBS/T, washed four 
times in blocking solution, and finally incubated with HRP-conjugated secondary 
antibody followed by washing in PBS/T. Blots were developed using the ECL Plus 
Western blotting detection system (GE Healthcare) according to the manufacturer’s 
instruction. Signal intensities were quantified with the Image J software (National 
Institute of Health). 
  
3.5. Cytotoxicity assays  
S. pombe — Transformed cells were grown in EMM complemented with 
appropriate supplements. To characterize the chemosensitivity of yeast strains in liquid 
medium, 100 μl overnight cultures (A600nm of 0.8) were diluted into 2 ml EMM containing 
different concentrations of metal compounds (Cd(II) As(III) As(V), Sb(III), Sb(V), 
Hg(II), Cu(II) or Zn(II)). In case of Sb(III) and Cu(II) we could not detect toxic 
concentrations in EMM medium. Cells were then grown at 30 °C, 200 rpm. After 72 h 
the extent of growth was determined by measuring absorbance at 600 nm (A600nm). 
Viability curves were fitted with Graph Pad Prism 5 software using the sigmoidal dose–
response model. To characterize chemosensitivity on agar plates, overnight cultures were 
diluted in EMM (A600nm of 0.7). Colonies were spotted onto plates containing different 
concentrations of metal compounds and incubated for 6-7 days at 30 °C.  
C. elegans —Experiments were performed by J. Barna and D. Kovács as described 
by Schwartz et al104. Adult worms were allowed to lay eggs for 2 hours at 20 °C on a 
medium containing 0, 5 µM and 10 µM CdCl2. Then the adults were removed from the 
plates, thus synchronized populations grew. Animals were allowed to grow for 4 days at 
20 °C. After 4 days, samples were taken from each plate, 20-20 animals/category were 
counted how many animals have reached adulthood or larval stages by light microscopy 
in 3 independent trials.  
Human cell lines — Living, proliferating cells maintain reducing environment 
within their cytosol. The PrestoBlue reagent contains a blue, nonfluorescent, cell-
permeant compound which can be modified by the reducing environment of the viable 




by using a plate reader such as Perkin-Elmer EnSpire. In cytotoxicity experiments the 
cells were seeded in 100 μl DMEM medium at a density of 4000 cells/well in 96-well 
plates, and serially diluted drugs were added the following day in 100 μl medium to give 
the indicated final concentration. Cells were then incubated for 72 h at 37 °C in 5% CO2. 
Cell survival was assessed by the PrestoBlue assay, according to the manufacturer's 
instructions. Viability curves were fitted with Graph Pad Prism 7 software using the 
sigmoidal dose–response model.  
Cytotoxicity assays were performed in triplicates 
 
3.6. Determination of the vacuolar cadmium content 
Vacuole isolation — S. pombe cultures were treated overnight with 20 μM CdCl2, 
then vacuoles were isolated with the valuable help of N. Kucsma as described earlier134, 
with some modifications. Briefly, 5 ml stationary phase cultures diluted in 25 ml of EMM 
were grown for 4-6 h at 30 °C. Next, 25 ml cultures were diluted in 200 ml EMM medium 
containing 20 μM CdCl2, and the cultures were grown for 18 h at 30 °C to an A600nm 
(OD600) of 1.5. Cells were pelleted by centrifugation at 3000 g for 5 min and were 
washed in 50 ml distilled water. After resuspension in 50 ml buffer (20 mM β-
mercaptoethanol, 100 mM Tris-HCl (pH 9.4)), cells were incubated for 20 min at 30 °C 
with gentle shaking. Spheroplasts were created by pelleting and suspending the cells in 
20 ml of digestion medium (DM: 1.2 M sorbitol (pH 7.5), 10 mM β-mercaptoethanol, 20 
mM potassium phosphate, 50 mg of Zymolyase 20T (ICN) and 100 mg of lysing enzymes 
from Trichoderma harzianum (Sigma-Aldrich) to disrupt cell wall). The suspension was 
incubated for 2 h at 30 °C with gentle shaking, followed by centrifugation at 3000 g for 
5 min. The spheroplasts were washed in 20 ml ice-cold homogenization medium (HM: 
1.6 M sorbitol, 10 mM MES-Tris (pH 6.9), 0.5 mM MgCl2, 5 mM β-mercaptoethanol, 
and to avoid protein degradation 1 mM phenylmethylsulfonyl fluoride, and 1 µg/ml each 
of leupeptin, aprotinin, and pepstatin (protease inhibitor cocktail, Sigma P8340 in 
500×dilution) were added). Pelleted spheroplasts were lysed in the same medium by 
homogenization in a 5-ml glass Dounce homogenizer. The crude lysate was cleared of 
cell debris and unbroken cells by centrifugation at 3000 g for 8 min. The supernatants 
were collected, and the pellet was resuspended in 3.5 ml HM, homogenized again (30X), 




35 min. The pellet, containing the partially purified vacuolar fraction was suspended in 
1.5 ml HM, layered onto 1 ml Sucrose step gradient (40%/50% (v/v)), and pelleted at 
40000 rpm using a Beckman Coulter 70.1 Ti rotor at 4 °C for 1 h. Purified vacuoles were 
suspended in 3 ml suspension medium (SM: 1.6 M sorbitol, 100 mM KCl, 10 mM MES-
Tris, pH 6.9, 5 mM MgCl2, and protease inhibitors) and were centrifuged at 4 °C at 13000 
g for 12 min in Eppendorf microcentrifuge. The final vacuolar pellet was stored at -80 
°C. 
Assessment of Integrity of Vacuole Preparations — The success of the 
measurement depended on intact vacuoles. With the help of Nóra Kucsma, the integrity 
of the vacuoles was assessed by measuring fluorescence as described135 based on that 
Acridin-Orange (AO, Sigma-Aldrich) indicates acidic compartments. In control 
experiments vacuoles were lysed with detergent destroying their lipid bilayer, so acidic 
pH was no longer sustainable. The decreased fluorescent signal of AO was measured 
using an Attune Acoustic Focusing cytometer (Applied Biosystems, Life Technologies, 
Carlsbad, CA, US).  
Determination of vacuolar Cd contents — Vacuolar Cd content was determined 
by graphite furnace atomic absorption spectrometry (GFAAS) performed by László 
Bencs and Norbert Szoboszlai. All GFAAS measurements were performed at Wigner 
Research Centre for Physics of HAS on an Analytik Jena Model ContrAA-700 tandem 
high-resolution AAS (Analytik Jena AG, Jena, Germany), equipped with an autosampler. 
Each final vacuolar pellet after the isolation was digested in 200 µl cc. (65% v/v) HNO3 
for 24 h at room temperature. After appropriate dilution, an aliquot of 20 µl of each 
sample was directly dispensed by the autosampler into the graphite tube (fitted with a 
graphite platform) to determine the concentration of Cd in the isolated vacuoles. The Cd 
228.8018 nm spectral line was selected for the determinations, with a 3-pixel evaluation 
of the CCD camera, which corresponds to a resolution of 3.78 pm at this wavelength. The 
GF heating program consisted of smooth drying (at 100 °C for 20 s, 110 °C for 5 s, 130 
°C for 10 s), pyrolysis (350 °C for 15 s, 450 °C for 10 s), atomization/measurement (at 
1200 °C for 3 s), and clean-out (2450 °C for 4 s) steps. In these steps, maximum flow (2 
dm3/min) of the GF sheath gas (5N Ar) was applied, except the atomization step under 
stopped air flow. Integrated absorbance signals were measured with signal integration 




corresponds to an average of three replicate determinations. For quantitative 
determinations, external standardization was applied by means of setting up five-point 
calibration curves (range: 1-50 ng/ml Cd, preserved in 2.6% HNO3). Recovery was 
checked by spiking selected samples with 5 µl of a Cd standard solution at a concentration 
of 500 ng/l and 50 ng/l. The precision of the determinations, expressed as relative standard 
deviation (RSD) was typically below 2.1%, but not worse than 5.3%. All Cd 
concentration data were normalized to the protein content of the samples. 
 
3.7. Measurement of melanin content 
Cells were seeded in 6-well plates at a density of 1×105 cells per well and were 
allowed to grow 48 hours. MNT-1 cells were washed with phosphate-buffered saline 
(PBS) and dissolved in 250 μl of 1 N NaOH for 1 hour at 80 °C. 100 µl sample was 
transferred to 96-well plates. Melanin contents were determined by measuring absorbance 
at a wavelength of 405 nm using a plate reader such as Perkin-Elmer EnSpire. 
 
3.8. Confocal microscopy 
Localization of ABCB6 in S. pombe — For the evaluation of intracellular 
localization of the transporters, hmt-1-deleted S. pombe was transformed with pREP1-
HMT-1-GFP or ABCB6-GFP. Cells were grown to mid-log phase (A600nm of 0.5-0.8) and 
stained with FM 4-64 (T3166 ThermoFischer Scientific Waltham, MA, USA) as 
described with the following modifications. FM4-64 dye was dissolved in DMSO at a 
concentration of 1.64 mM. Cells were harvested and incubated with 1 μl FM4-64 in 50 
μl EMM medium at 30 °C for 20 min to internalize the dye (on ice endocytosis is inhibited 
and the dye stains the plasma membrane). Excess dye was washed with 1 ml EMM, cells 
were centrifuged at 5000 g for 5 min at RT. The cell pellet was resuspended in 5 ml EMM, 
and the suspension was shaken at 30 °C for 90 min for enrichment of the dye in the 
vacuolar membrane. The total volume was transferred to a centrifuge tube and spun for 5 
min at 5000 g at room temperature (RT). The cell pellet was resuspended in 1 ml sterile 
water and centrifuged at 5000 g for 5 min at RT. Cells were resuspended in 25 μl EMM. 
7 μl was spotted on ConA/polyK-coated (1:1 mixture of 2 mg/ml concanavalin A and 
0.1% poly-L-lysine) glass slides covered with an 18 x 18 mm2 cover slip. This mixture 




polysaccharides and negatively charged proteins in the cell wall. Confocal images were 
obtained using LSM 710 confocal laser scanning microscope (Carl Zeiss AG, 
Oberkochen, Germany) equipped with a Plan-Apochromat 63×/1.4 Oil DIC M27 
objective. Noise reduction and deconvolution of the images were performed with 
Huygens Essential (Scientific Volume Imaging B.V.). 
Localization of ABCB6 in C. elegans — Experiments were performed by J. Barna 
and D. Kovács and confocal images were made by N. Kucsma. Transgenic strains were 
grown in normal growth conditions at 20 °C. To test the subcellular co-localization of 
ABCB6 and CeHMT-1, the phmt1::ABCB6::mCherry (TTV677) strain was crossed with 
phmt-1::HMT-1::GFP (VF31) males and the F1 progeny co-expressing both transgenes 
was examined with a confocal microscope (Zeiss LSM 710, Plan-Apochromat 63×/1.4 
NA Oil DIC M27objective). To prepare the sample, animals were plated on a 5% agar 
surface onto the slide in M9 physiological buffer (20 mM KH2PO4, 40 mM Na2HPO4, 85 
mM NaCl, 1 mM MgSO4, pH 7). Their motion was paralyzed by levamizole dropped onto 
agar, which acts as a nerve poison, being an agonist of the α-subunit of the L-subtype 
nicotinic acetylcholine receptor136. Lysosomal staining was performed as described. L4 
larvae/young adult animals were placed on an OP50 grafted NGM plate containing 2 µM 
LysoTracker Red. Animals spent 12-48 hours in the absence of light then they were 
directly examined after removal from agar plates. To determine the subcellular 
localization of CeHMT-1::GFP and ABCB6::GFP, phmt-1::hmt-1::gfp (VF11) and phmt-
1::abcb6::gfp (TTV634) were crossed with strains expressing different endosomal 
markers 137,138, resulting in TTV700 unc-119(ed3)III; eluIs310[phmt-1::ABCB6::gfp + 
unc-119(+)]; TTV701 unc-119(ed3)III; eluIs310[phmt-1::ABCB6::gfp + unc-119(+)]; 
qxIs110(Pges-1mCHERRY::RAB-5), TTV702 unc-119(ed3)III; eluIs310[phmt-
1::ABCB6::gfp + unc-119(+)]; qxIs111(Pges-1mCHERRY::RAB-7), TTV703 unc-
119(ed3)III; eluIs310[phmt-1::ABCB6::gfp + unc-119(+)]; qxIs213(Pges-
1mCHERRY::RAB-10), TTV705 unc-119(ed3)III; gfIs1[phmt-1::hmt-1::gfp, unc-
119(+)]; qxIs110(Pges-1mCHERRY::RAB-5), TTV706 unc-119(ed3)III; gfIs1[phmt-
1::hmt-1::gfp, unc-119(+)]; qxIs111(Pges-1mCHERRY::RAB-7), TTV707 unc-119 
(ed3)III; gfIs1[phmt-1::hmt-1::gfp, unc-119(+)]; qxIs213(Pges-1mCHERRY::RAB-10). 
Localization of ABCB6 in human cells — Confocal images were made by 




were plated in an Eppendorf 8 well imaging coverglass (#0030742036). Hoechst 33342 
was applied to the cells 20 min prior to fixation, subsequently cells were rinsed in PBS 
and fixed for 30 min in 4% PFA/PBS at RT. Fixed cells were quenched for 10 min in 
PBS/100 mM glycine (quenching buffer), washed with PBS and blocked and 
permeabilized in PBS containing 0.2 mg/ml BSA/0.1% Triton X-100/ 10% Normal Goat 
Serum (blocking buffer). The primary antibody was diluted in PBS containing 0.2 mg/ml 
BSA, 0.1% Triton X-100 and 3% Normal Goat Serum (incubation buffer, IB). Cells were 
incubated with the primary antibody overnight at 4 °C in a humidified chamber, washed 
five times in IB, and incubated with the corresponding secondary anti-human, anti-rabbit 
and anti-mouse antibodies conjugated to Alexa Fluor 488 or Alexa Fluor 647 diluted in 
IB for 90 min at RT. Samples were washed five times with PBS and subsequently imaged. 
Confocal images were obtained using LSM 700 or LSM 880 confocal laser scanning 
microscope (Carl Zeiss, Inc.) equipped with a Plan-Apochromat 63x/1.4 NA Oil DIC 
M27 objective. Images were acquired in three channels (blue (Hoechst 33342), green 
(Alexa Fluor 488), red (Alexa Fluor 647), blue emitting Hoechst 33342) was excited using 
the 405 nm laser line, green emitting Alexa Fluor 488 was excited using the 488 nm laser 
line and infrared emitting Alexa Fluor 647 was excited using the 633 nm laser line. Noise 
reduction and deconvolution of the images was performed with Huygens Essential 
(Scientific Volume Imaging B.V.). Colocalization analysis was performed with ImageJ 
(National Institute of Health) using the JACoP v2.0 plugin. 
Antibodies and dyes — Monoclonal antibodies, dyes and their sources were as 
follows: ß-actin (A1978, Sigma-Aldrich, Saint Louis, MO, USA); anti-EGFP (ab184601 
Abcam, Cambridge, UK), ABCB6-567139, anti-HA antibody, (H6908 Sigma-Aldrich). 
HRP-dependent luminescence was detected using the enhanced chemiluminescence 
technique (ECL, Amersham). Rabbit monoclonal Anti-AIF [D39D2] antibody (#5318) to 
apoptosis inducing factor, rabbit monoclonal Anti-EEA1 [C45B10] antibody (#3288) to 
early endosome antigen 1, rabbit monoclonal Anti-LAMP1 [D2D11] antibody (#9091) to 
lysosome-associated membrane protein 1, secondary goat anti-mouse IgG (H+L) F(ab’)2 
fragment conjugated to Alexa Fluor 647 (#4410) and secondary goat anti-rabbit IgG 
(H+L) F(ab’)2 fragment conjugated to Alexa Fluor 647 (#4414) were from Cell Signaling 
Technology. Secondary goat polyclonal antibody to human IgG conjugated to DyLight 




counterstain was from Thermo Fisher Scientific. The OSK43 antibody was a kind gift 
from Dr. Yoshihiko Tani (Japanese Red Cross Osaka Blood Center, Osaka, Japan). 
Mouse monoclonal Anti-Melanoma Associated Antigen 100+/7 kDa [Nki/beteb] 
antibody (ab34165) and mouse monoclonal Anti-Melanoma [HMB45] antibody (ab787) 
to melanocyte protein (PMEL), mouse monoclonal Anti-TRP-1 [TA99] antibody 
(ab3312) to tyrosinase-related protein 1(TRP1), secondary goat polyclonal antibody to 
human IgG conjugated to DyLight 488 (ab96907) and horseradish peroxidase-conjugated 
goat polyclonal antibodies to rabbit IgG (ab6721) and to mouse IgG (ab6789) were from 
Abcam. Rabbit monoclonal Anti-AIF [D39D2] antibody (#5318) to apoptosis inducing 
factor, rabbit monoclonal Anti-Calnexin [C5C9] antibody (#2679) to Calnexin, rabbit 
monoclonal Anti-RCAS1 [D2B6N] to receptor binding cancer antigen expressed on SiSo 
cells (#12290), rabbit monoclonal Anti-EEA1 [C45B10] antibody (#3288) to early 
endosome antigen 1, rabbit monoclonal Anti-LAMP1 [D2D11] antibody (#9091) to 
lysosome-associated membrane protein 1, secondary goat anti-mouse IgG (H+L) F(ab’)2 
fragment conjugated to Alexa Fluor 647 (#4410) and secondary goat anti-rabbit IgG 
(H+L) F(ab’)2 fragment conjugated to Alexa Fluor 647 (#4414) were from Cell Signaling 
Technology. Secondary goat anti-rabbit IgG (H+L) antibody conjugated to Alexa Fluor-
488 (A-11034) and Hoechst 33342 (R37605) nuclear counterstain were from Thermo 
Fisher Scientific. The OSK43 antibody was a kind gift from Dr Yoshihiko Tani (Japanese 
Red Cross Osaka Blood Center, Osaka,Japan)82. ABCB6 ((61.5): sc-135726) mouse 
monoclonal antibody was from Santa Cruz Biotechnology.  
 
Electron microscopic images and analysis were made by Guillaume van Niel, 
Ptissam Bergam and Graca Raposo.  
 
3.9. Genome editing by CRISPR/Cas9 
Fluorescent in situ hybridization (FISH) — ABCB6 specific FISH probe and 
Chromosome II control probe (Orange / Green SKU ABCB6-CHR2-20-ORGR, 
premixed) was purchased from Empire Genomics (Williamsville, NY, USA). The 
cytogenetic analysis and FISH hybridization protocol was implemented by Gergő Papp 
(1st Department of Pathology and Experimental Cancer Research, Semmelweis 
University, Budapest). Cells for cytogenetic analysis were stained by the modified 




pH 7.2) and Giemsa dye for 5-10 minutes). For FISH analysis 40,000 cells were washed 
in PBS then transferred and dried on microscopic slide with cytospin centrifuge. After 
drying, samples were fixed in methanol-acetic acid. The probe and the cells were co-
denatured at 73 °C, then 10 μl probe mixture was added to the slide (2 μl ABCB6 probe, 
2 μl Chromosome II probe, 6 μl hybridization buffer) and hybridized at 37 °C for 16 
hours. 10 μl DAPI was applied and the samples were visualized under fluorescent 
microscope. 200 cells in interphase per sample were analyzed for the FISH pattern. Nikon 
Eclipse E600 epi-fluorescent microscope (with DAPI, spectral-green and spectral-orange 
filter kits) and Lucia Cytogenetics (Laboratory Imaging) image analysis software were 
used. 
CRISPR/Cas9 system — Clustered regularly interspaced short palindromic repeats 
(CRISPR)/Cas technology was used to modify the endogenous ABCB6 gene in human 
MNT-1 cell line. Breaks in the targeted genomic position caused by SpCas9 involving 
one or both strands are effectively repaired by the cell using one of the two main repair 
pathways. The homology-directed repair (HDR) or the more error prone non-homologous 
end-joining (NHEJ). In the first cell lines we used HDR to modify ABCB6 alleles 
(ABCB6-GFP, ABCB6-SBP-GFP), while we used NHEJ to generate ABCB-KO cells. 
Establishing the ABCB6-GFP, ABCB6-SBP-GFP, ABCB6-KO cell lines — To create 
ABCB6-GFP and ABCB6-SBP-GFP cells, 3x105 MNT-1 cells were transfected using 6 
µl Lipofectamine 2000/well (Thermo Fisher Scientific) in 6 well plates. Three types of 
plasmids were co-transfected: donor plasmid (pCDNA), SpCas9 expression plasmid 
(pX330) and gRNA (pColEI_U6) expression plasmid (Table 2, Table S2). In case of the 
negative controls, the pEGFP-N1 plasmid was used instead of the donor plasmid. Because 
of the moderate efficiency of the transfection in MNT-1 cells, to create ABCB6-KO cells, 
we used UO24 program of Nucleofector II (Amaxa-Lonza, Basel, Switzerland). 2x106 
cells were electroporated based on the protocol of Vriend and colleagues140. Transfected 
or electroporated cells were analyzed 8-days post-transfection (no background signal 
from plasmid was detected anymore) and cells were sorted by FACS Aria III Cell sorter 
(BD Biosciences) FACS and cloned on 96 well plates by serial dilution141 or 0.5 cell/well 
dilution. To make the detection of single cells in the wells easier, Calcein AM assay was 
performed. Calcein AM is a cell-permeant dye that can be used to determine cell viability 




green-fluorescent calcein after acetoxymethyl ester hydrolysis by intracellular esterase. 
Cells were incubated in medium containing 0.25 μM Ca-AM for 30 min at 37 °C with 
5% CO2. After incubation the 96 well plates were imaged by High-content analysis 
system (IXM XLS Fluid, Molecular Devices).  
 
Table 2. ABCB6 constructs using CRISPR/Cas9 
  
Single cell clones were grown in the mix of conditioned and fresh MNT-1 medium 
(1:1 ratio) for 7 days at 37 °C with 5% CO2. Then the plates were imaged again after 
incubation with Calcein AM and clones originated from one single cell were selected. 
After several weeks clones were tested and selected by combination of the following 
methods: Sanger sequencing, Real Time-PCR, immunoblot, FACS and confocal 
microscopy. PCR reactions and sequencing were applied with the appropriate primer 
pairs (Table S1) to detect integration or indel (insertion/deletion) events at the adjacent 
location of the double strand break caused by SpCas9. In addition, we tested clones for 
integrated SpCas9 coding sequence in their genome by PCR and excluded those where 
integration occurred.  


































• pCDNA3: GFP between 
homologous arms (933 ng) 
• pX330: WT SpCas9 coding 
plasmid (233 ng) 
• pColEI_U6: ABCB6 
gRNA coding plasmids 
(167ng) 
molar ratio: 4;1;1 
• pCDNA3: SBP–GFP 
between homologous 
arms (933 ng) 
• pX330: WT SpCas9 
coding plasmid (233 ng) 
• pColEI_U6: ABCB6 
gRNA coding plasmids 
(167 ng) 
molar ratio: 4;1;1 
• pCMV_BFP_U6: 
ultimate target + BFP 
coding plasmid (1,9 µg) 
• pX330: WT SpCas9 + 
ABCB6 gRNA coding 
plasmids (1,9 µg) 
• pColEI_U6: ultimate 
spacer gRNA (1,2 µg) 
































Retention Using Selective Hooks (RUSH) — To follow and understand the 
pathway of the protein in the cell, we tried to take advantages of a recently discovered 
method, the RUSH system. RUSH is a two-state assay based on the reversible interaction 
of a hook protein in a donor compartment and the protein of interest. Streptavidin binding 
peptide (SBP) sequence was cloned into earlier used pCDNA3 plasmid, upstream to GFP 
sequence. Cells were transfected according to Table 3. Thus, we create SBP-GFP tagged 
ABCB6 alleles. The other component of RUSH system, the hook in the ER will be a 
transiently expressed in future work. CD74 (HLA class II histocompatibility antigen 
gamma chain) protein fused to streptavidin (Sa) which contains an ER retention signal 
sequence will function as a transmembrane protein which will anchor the SBP-GFP 
tagged ABCB6. Biotin added to the media will bind to Sa, releasing ABCB6. 
Genomic DNA (gDNA) extraction — Genomic DNAs were purified from 
genetically modified clones. 1x106 cells were harvested, washed in PBS and centrifuged 
at 1000 g for 10 minutes. Genomic DNA was purified according to Puregene DNA 
Purification protocol (Gentra systems) and concentration was measured by NanoDrop 
OneC Microvolume UV-Vis Spectrophotometer. 
RT-PCR — To determine the integrated EGFP copy number and thus the copy 
number of tagged ABCB6, we used a TaqMan assay. TaqMan Gene Expression Master 
Mix was applied (Thermo-Fischer Scientific 4369016) and K. Hupcsik helped us (HAS 
RCNS, EI). TaqMan Gene Expression Master Mix is an optimized 2x mix that contains 
all of the components, excluding the template and primers, for sensitive detection down 
to one copy of target. qPCRs were measured in triplicate and run on a StepOne Plus real-
time device (Thermo-Fischer Scientific). We used standard temperature profile (95 °C 10 
min, 40 cycles 95 °C 15 sec and 60 °C 1 min). The following primers and probes were 
used: Ribonuclease P RNA Component H1 (RPPH1, endogenous control) for 5’ – 
AGCTGAGTGCGTCCTGTCACT, rev 5’ – TCTGGCCCTAGTCTCAGACCTT, probe 
5’ – CACTCCCATGTCCCTT; GFP for 5’- GAGCGCACCATCTTCTTCAAG, rev 5’ – 
TGTCGCCCTCGAACTTCAC, probe 5’ – ACGACGGCAACTACA. In 20 µl final 
volume 100 ng gDNA, 900 nM primer and 250 nM probe were added to the TaqMan 
master mix. For reference HEK293 cell clones were used bearing 1, 4 or 7 copies of 
RPPH1. 142 Data were analyzed by StepOne 2.1 software, after optimization ΔΔCt method 






4.1. The relation of ABCB6 function to the HMT-1 proteins 
Intracellular localization of ABCB6 has been a matter of debate, with conflicting 
reports suggesting mitochondrial or endolysosomal expression. ABCB6 shows 
significant sequence identity to HMT-1 (heavy metal tolerance factor 1) proteins, whose 
evolutionarily conserved role is to confer tolerance to heavy metals by the intracellular 
sequestration of metal complexes. We used the NCBI Blastp algorithm to quantify 
sequence similarity of ABCB6 and HMT-1 proteins (Table 3). We hypothesized that the 
cadmium-sensitive phenotype of HMT-1-defective S. pombe and C. elegans strains can 
be rescued by human ABCB6 protein.  
 
Table 3. Clustal2.1 Percent Identity Matrix Sequence similarity was quantified using the NCBI 
Blastp algorithm (https://blast.ncbi.nlm.nih.gov/BlastAlign.cgi). 
 
 
4.1.1. Heterologous expression of SpHMT-1 and ABCB6 transporter in S. 
pombe model organism 
S. pombe is a classic laboratory organism, and evolutionarily closer to animal cells 
than budding yeast (S. cerevisiae), thus it serves as an important model for elucidating 
conserved pathways and processes relevant to human diseases.  
After verifying that the hmt-1 deleted cells are significantly more sensitive to Cd 
than the wild type (WT) cells, we engineered plasmids enabling the heterologous 
expression of SpHMT-1 and ABCB6. The cDNA encoding hmt-1 and C-terminal HA-tag 
was ordered from GenScript. HA-tag was necessary because an HMT-1 specific 
monoclonal antibody was not available in our lab. The cDNAs of SpHMT-1 and human 
ABCB6129 were cloned into the pREP1 yeast expression vector yielding pREP1-HMT-1-
 SpHMT-1 CeHMT-1 DmHMT-1 HsABCB6 
SpHMT-1 100.00  35.68 40.42  39.20 
CeHMT-1 35.68  100.00 45.69  46.19 
DmHMT-1 40.42  45.69 100.00 50.43 




HA and pREP1-ABCB6. Plasmid was transformed into hmt-1 deleted (hmt-1Δ) yeast 
cells. As a control, both strains (WT and hmt-1Δ) were transformed with empty pREP1 
vector. Exogenously expressed HMT-1 was detected with an HA-specific antibody on 
immunoblot (Fig. 8A first lane). Human ABCB6 was detected by ABCB6-567 antibody 
was produced against an extracellular epitope of the protein139. Heterologous expression 
of a human glycosylated membrane transporter in an evolutionally lower, unicellular 
organism is not straightforward. But ABCB6 and ABCB6-KM was produced in relatively 
high amounts in yeast cells (Fig. 8A). The ABCB6 specific antibody also recognized 
SpHMT-1 protein (Fig. 8B). The cross reaction can be explained by the sequential 
similarity between the two proteins.  
 
 
Figure 8. Immunoblot analysis of yeast cells. A Hmt-1-deleted cell expressing HMT-1-HA, 
HMT-1-GFP, ABCB6, ABCB6-KM or ABCB6-GFP. Expression of HMT-1 was revealed by 
using anti-HA antibody; ABCB6 was labeled by the ABCB6-567 antibody; EGFP tagged proteins 
were labeled by an anti-EGFP antibody. 50 µg total cell lysates were analyzed132. B ABCB6-567 
antibody recognizes HMT-1 protein. No signal was detected in hmt-1Δ vector control cells, but 
specific bands were developed in WT vector control cells and HMT-1-HA expressing WT and 
hmt-1Δ cells. 50 µg total cell lysates were analyzed. 
 
4.1.2. Heterologously expressed human ABCB6 localizes to the vacuolar 
membrane of S. pombe 
HMT-1 is localized in the vacuolar membrane of the yeast cell. Addressing this 
purpose, GFP-tagged hmt-1 and ABCB6 DNA constructs were engineered and expressed 
in S. pombe (Fig 8A). After successful expression of the fusion proteins HMT-1-GFP and 
ABCB6-GFP, cells were stained with FM 4-64 which selectively stains the vacuolar 
membrane. A similar intracellular pattern was observed in both cases in confocal 
microscopic images, which indicated that the human ABCB6 protein was targeted to the 






Figure 9. ABCB6-GFP localizes to vacuoles of S. pombe. Hmt-1-deleted S. pombe was 
transformed with pREP1-HMT-1-GFP or ABCB6-GFP (green); vacuoles were stained with FM 
4-64 (red). Insets show individual cells. Scale bar 10 μm132. 
 
4.1.3. Heterologous expression of human ABCB6 restores cadmium 
tolerance of S. pombe hmt-1Δ mutants 
Cd-sensitivity of the cells was examined by cytotoxicity assays in liquid culture and 
on solid medium. Cd-tolerance of hmt-1-deleted strains was increased when HMT-1-HA 
was expressed, suggesting that the protein could protect the hmt-1-deleted yeast strains 
from cadmium toxicity, i.e. the detoxifying function of the protein was not affected by 
the HA-tag. (Fig. 10A,B). To test whether ABCB6 can fulfil a detoxification function 
similar to HMT-1, we expressed the wild-type human ABCB6 protein and its catalytically 
inactive mutant variant (ABCB6-KM) in hmt-1-deleted strain. It was detected that 
expression of wild-type ABCB6 also restored cadmium tolerance, allowing transformed 
S. pombe colonies to grow in the presence of Cd (Fig. 10A). However, in the case of the 
inactive, Walker A mutant variant of ABCB6, the rescue effect could not be observed, 
suggesting that functional ABCB6 is needed to restore the tolerance. The cytotoxicity 







Figure 10. ABCB6 confers cadmium tolerance in hmt-1Δ mutant S. pombe. A Wild-type S. 
pombe cells transformed with empty pREP1 vector (WT); hmt-1Δ mutant cells transformed with 
empty pREP1 vector (hmt-1Δ), pREP1-HMT-1-HA (hmt-1Δ/SpHMT-1-HA), pREP1-ABCB6 
(hmt-1Δ/ABCB6) or pREP1-ABCB6-KM (hmt-1Δ/ABCB6-KM) were grown overnight. 
Aliquots of the cell suspensions were then serially diluted (A600nm of 0.7) and spotted onto solid 
EMM supplemented with adenine, uracil and the indicated concentrations of CdCl2. Colonies 
were visualized after incubating the plates for 8 days at 30 °C. B Transformed yeast cells were 
grown overnight to an A600nm of 0.8-1. 100 μl aliquots were inoculated into 2 mL of the same 
medium containing CdCl2 at the indicated concentrations. A600nm was measured after growth at 30 
°C for 72 h. Values, expressed as viability (%), were normalized to untreated control (n=3)132. 
 
4.1.4. S. pombe functional assay 
This functional assay gave us the opportunity to examine mutant variants of 
ABCB6. Mutant constructs (Table 4) were cloned into pREP1 plasmid, then expressed in 
fission yeast cells. Similarly to the wild type and the inactive (K629M) mutant variant of 
ABCB6, the tested mutants were successfully expressed in fission yeast cells (Fig. 11A). 
In cytotoxicity experiments cells were spotted on agar plates using OD=0.8 and OD=0.08 
dilutions. Only two of the tested mutants failed to revert the Cd-tolerant phenotype. Cells 
expressing Lan mutants R192W and R276W (Table 4) could not grow on solid media 
containing 50 μM Cd (Fig. 11B red arrows). In contrast, disease associated mutants 
S170G (DUH) or A57T (ocular coloboma) and other Lan mutants (R192Q, G588S, 




Table 4. ABCB6 variants tested in S. pombe cytotoxicity experiments 
Amino acid change Nucleotide change Phenotype References 
A57T 169G>A Coloboma 75 
S170G 508A>G DUH 30 
R192Q 575G>A Lan 29 
R192W 574C>T Lan 29,80,82 
R276W 826C>T Lan 29,80,82 
G588S 1762G>A Lan 29,80,82 
V609M 1825G>A Lan 85 
R638C 1912C>T Lan 85 
  
 
Figure 11. ABCB6 mutant variants were expressed and tested in S. pombe Cd-cytotoxicity 
assay. A Immunoblot analysis of mutant ABCB6 variants. Hmt-1Δ mutant cells were transformed 
with empty pREP1 vector (hmt-1Δ), or pREP1 vector containing ABCB6 variants. Expressions 
were revealed by the ABCB6-567 monoclonal antibody. 50 µg total cell lysates were analyzed. 
B Wild-type S. pombe cells were transformed with empty pREP1 vector (WT); hmt-1Δ mutant 
cells transformed with empty pREP1 vector (hmt-1Δ), or the mutant variant containing pREP1 
plasmids. Cells were grown overnight and aliquots of the diluted cell suspensions (A600nm of 0.8: 
1x and 10x dilution) were then spotted onto solid EMM supplemented with adenine, uracil and 
the indicated concentrations of CdCl2. Colonies were visualized after incubating the plates for 8 




We tested further metals in our rescue model system based on earlier finding, that 
CeHMT-1 can provide tolerance to cadmium, arsenic and copper104. In addition, 
experimental results supporting the role of ABCB6 in arsenic resistance were also 
reported45,46,143. Cytotoxicity assays revealed that the expression of ABCB6 in hmt-1Δ S. 
pombe cells conferred slight resistance to As(III) but not to As(V), Sb(V), Hg(II) or Zn(II) 
(Fig. 12). In case of Sb(III) and Cu(II) we could not detect toxic concentrations in EMM 
medium (data not shown). 
 
 
Figure 12. ABCB6 mediates resistance to As(III) in hmt-1Δ mutant S. pombe. Yeast cells 
were grown overnight to an A600nm of 0.8-1. 100 µL aliquots were inoculated into 2 mL of the 
same medium containing the indicated concentrations of metal complexes. Absorbance was 
measured after growth at 30 °C for 48 h. Values, expressed as viability (%), were normalized to 
untreated control (n=2)132. 
 
4.1.5. Determination of vacuolar cadmium contents 
Intracellular concentrations of cadmium are decreased by SpHMT-1, which 




results, we wanted to find further direct evidence proving the orthologous function. Intact 
vacuoles were isolated from Cd treated yeast cells and their Cd content was measured by 
graphite furnace atomic absorption spectrometry (GFAAS), performed by L. Bencs and 
N. Szoboszlai. Before the Cd measurement, integrity of the purified vacuoles was 
confirmed by the following method. First, isolated organelles were stained with Acridine-
Orange (AO) labeling the acidic compartments, then vacuoles were lysed with the 
detergent TritonX. Detergent treatment destroyed the lipid bilayer of vacuoles, acidic pH 
was no longer sustainable thus the signal of AO decreased. The change of fluorescent 
signals was measured by Attune NxT flow cytometer, performed by Nóra Kucsma (Fig. 
13).  
 
Figure 13. Assessment of vacuolar integrity. After incubation with 30 μM Acridine-Orange 
(AO) for 10 min integrity of the vacuoles was assessed by measuring fluorescence signal (red 
histograms). In control experiments (purple histograms), vacuoles were treated with 0,1% 
TritonX for 10 min after AO staining. Fluorescence was measured using an Attune Acoustic 
Focusing cytometer132. 
 
Compared to the wild-type, isolated vacuoles from hmt-1-deleted strains contained 
significantly less cadmium, in line with the absence of vacuolar sequestration. But 
vacuolar Cd content was restored when cells expressed SpHMT-1 or ABCB6 (Fig. 14). 
As it appeared in cytotoxicity assays, increased vacuolar accumulation of cadmium was 
dependent on the functionality of ABCB6, indicating that the rescue of hmt-1-deleted 






Figure 14. ABCB6 restores vacuolar Cd levels in hmt-1Δ mutant S. pombe. Yeast cells lacking 
SpHMT-1 (hmt-1Δ) were engineered to express ABCB6, ABCB6-KM or SpHMT-1. 
Transformed cells were cultured for 18 h in growth medium supplemented with 20 μM CdCl2. 
Intact vacuoles were isolated by differential centrifugation; the Cd content of the isolated vacuoles 
was quantified by AAS (atomic absorption spectrophotometer). Data show average Cd levels 
relative to control calculated from independent experiments (n=3). All Cd concentration data were 
normalized to the protein content of the samples132. 
 
4.1.6. Human ABCB6 rescues the Cd Hypersensitivity of hmt-1-deleted C. 
elegans  
Our next goal was to investigate the function of the heterologously expressed 
human ABCB6 protein in a multicellular organism. HMT-1 proteins of S. pombe and C. 
elegans have been shown to share an orthologous function101. We hypothesized that 
ABCB6 can also rescue the Cd-sensitive phenotype of HMT-1-deficient C. elegans 
worms like in the case of S. pombe. Experiments were implemented by J. Barna from 
research group of T. Vellai (Department of Genetics, Eötvös Loránd University). In adult 
worms, CeHMT-1 is expressed in coelomocytes, intestinal cells and in head and tail 
neurons. An adult nematode has six coelomocytes which have been suggested to serve an 
immune, scavenging and hepatic functions because of their ability to continuously 
endocytose and accumulate a variety of macromolecules from the body cavity fluid105,144.  
To express the human ABCB6 transporter in nematode, codon optimized ABCB6 
cDNA was synthetized by GenScript and cloned into pPD95.75-GFP C. elegans 
expression plasmid. As a regulatory element for transcription, promoter of hmt-1 gene of 
the nematode was used. After transformation, animals bearing the selection marker were 
chosen. Transgenic animals could be easily identified on immobile Unc phenotype 
background, because the wild allele of the co-transformed unc-119 gene rescues 




HMT-1-GFP (VF31) was provided by the Vatamaniuk lab (Cornell University). Adult 
hermaphrodites were allowed to lay eggs onto NGM plates supplemented with the 
indicated concentrations of CdCl2, and the progeny reaching adulthood was counted 3 
days after hatching at 20 °C. As expected, wild type animals tolerated 10 μM CdCl2, while 
the hmt-1 (gk161) deletion mutant were sensitive to Cd, as no adult animal was observed 
after 4 days on Cd-containing plates. Expression of ABCB6 in the wild type background 
did not change Cd tolerance of the animals (not shown). This meant that integration of 
the transgene into the genome did not alter the heavy metal tolerance of the animals, and 
they developed normally on plates containing cadmium. In addition, integration of the 
transgene had no effect on the developmental rate of the worms. As described earlier105, 
expression of CeHMT-1 rescued the Cd-sensitive phenotype of hmt-1(-) strain. 




Figure 15. ABCB6 rescues the Cd-sensitive phenotype of HMT-1-deficient nematodes. A 
Wild-type (WT), hmt-1-deleted [hmt-1(-)], hmt-1-deleted expressing CeHMT-1::GFP [hmt-1(-); 




individually onto NGM plates supplemented with the indicated concentrations of Cd, and were 
allowed to lay eggs for 2 hours. Shown are the percentages of the progeny reaching adulthood 3 
days after hatching (mean of 3 independent trials). ***: Student’s T test, p < 0,001; bars represent 
±SD). B Representative pictures of animals grown on plates containing 10 µM CdCl2, 3 days after 
hatching at 20 °C. Heterologous expression of the human ABCB6 protein provided partial rescue, 
allowing the development of small sized adults, whereas hmt-1-deleted animals were arrested at 
the L2 – L3 larval stages132. 
 
We had to make sure that the rescue was not caused by the transgene integration 
into the genome, influenced the function of a gene that had any effect on animal's heavy 
metal tolerance. Therefore, J. Barna and D. Kovács performed an experiment on animals 
carrying ABCB6::gfp transgene on an extrachromosomal array. In the hmt-1(-) mutant, 
the extrachromosomal ABCB6 transgene also partially rescued the phenotype. While at 
5 µM and 10 µM Cd exposure none of hmt-1(-) animals reached adulthood, the deletion 
mutant expressing ABCB6 was also partially rescued (Fig. 16). Compared to the 
integrated ABCB6, weaker effect can be explained by the mosaicism of the worms: not 
all of the cells contained ABCB6 transgene. 
 
 
Figure 16. Animals carrying ABCB6::gfp transgene on an extrachromosomal array. Wild-
type (WT), hmt-1-deleted [hmt-1(-)], hmt-1-deleted expressing ABCB6::GFP [hmt-1(-); 
ABCB6::gfp_ex] adult hermaphrodites were placed individually onto NGM plates supplemented 
with the indicated concentrations of Cd, and were allowed to lay eggs for 2 hours. Shown are the 
percentages of the progeny reaching adulthood 3 days after hatching (mean of 3 independent 
trials). ***: Student’s T test, p < 0,001; bars represent ±SD) (unpublished data). 
 
4.1.7. Heterologously expressed human ABCB6 localizes to endolysosomes of 
C. elegans. 
After functional rescue was verified, localization of the transporters was also 




strain. Crossing the strains expressing CeHMT-1-GFP and ABCB6-mCherry allowed the 
simultaneous evaluation of the distribution of both transporters in C. elegans. Images 
obtained by confocal microscopy indicated that ABCB6 is expressed in the same tissues 
as CeHMT-1 (Fig. 17).  
 
 
Figure 17. Confocal microscopy images of an adult nematode co-expressing 
ABCB6::mCherry and CeHMT-1::GFP. Crossing of strains expressing CeHMT-1:GFP and 
ABCB6::mCherry proved that the two transporters are expressed in identical subcellular 
compartments (scale bar: 100 μm). Boxed areas are shown at a higher magnification (scale bar 20 
and 5 μm). Note that the ABCB6::mCherry strain carries the transgene extrachromosomally, 




Figure 18. ABCB6 and CeHMT-1 does not colocalize with lysosomal marker in C. elegans. 




described146. The panels show the DIC images (left) the GFP (green) and the Lysotracker (red) 
signals and the overlay of the two (right). Scale bar: 20 μm132. 
 
Next, we investigated the subcellular localization of CeHMT-1 and ABCB6. 
Intracellular organelles corresponding to the sites of CeHMT-1-GFP or ABCB6-GFP 
expression proved to be distinct from Lysotracker Red-positive lysosomes145 (Fig. 18). 
This was unexpected, because based on our previous results67, we assumed that ABCB6 
would colocalize with the lysosomal marker. 
Further localization studies were done by applying transgenic strains that express 
fluorescently labeled endosomal proteins. Nematodes expressing fluorescent RAB 
proteins were provided by Dr. Xiaochen Wang. Phmt-1::hmt-1::gfp and phmt-
1::ABCB6::gfp worms were crossed with pges-1::mCherry::RAB-5, pges-
1::mCherry::RAB-7, pges-1::mCherry::RAB-10 strains147, which express the fluorescent 
mCherry protein in different endocytic compartments. Analysis of the transgenic strains 
showed that CeHMT-1 and ABCB6 partially colocalize with markers of the early, late 
and basolateral recycling endosomes (mCherry::RAB-5, mCherry::RAB-7 and 






Figure 19. CeHMT-1 and ABCB6 show identical endosomal localization in nematodes. 
CeHMT-1 and ABCB6 partially colocalize with markers of the early, late and basolateral 
recycling endosomes. Subcellular localization of ABCB6 and CeHMT-1 was determined by 
confocal microscopy. Strains expressing CeHMT-1::GFP or ABCB6::GFP were crossed with 
worms expressing RAB-5::mCherry (early endosomal marker, A) or RAB-7::mCherry (late and 
early endosomal marker, B), or RAB-10::mCherry (basolateral recycling endosomes marker, C). 
The panels show the DIC images (left) the GFP (green) and the mCherry (red) signals and the 





4.1.8. Human ABCB6 confers Cd tolerance to SNB-19 glioblastoma cells  
After exploring the function of ABCB6 in heterologous model systems, we wanted 
to investigate the relevance of ABCB6 in heavy metal detoxification in a human cell line 
as well. To generate ABCB6 overexpressed or silenced cell lines for human metal toxicity 
studies lentiviral expression system was used (N. Kucsma). Immunoblot analysis of the 
overexpressing cells showed 30-40-fold increase in ABCB6 protein level and in the case 
of RNA silenced cells amount of protein was one eighth (Fig. 20A). 
 
 
Figure 20. Overexpression or attenuation of ABCB6 modulates Cd sensitivity in SNB-19 
cells. A Expression of ABCB6 from total cell lysates was monitored by immunoblot, using the 
anti-ABCB6 antibody ABCB6-567139. Whole cell lysates of SNB-19 cells (80 μg protein, lane 1), 
cells overexpressing ABCB6 (8 μg protein, lane 2), and cells transfected with a control (80 μg 
protein, lane 3) or an anti-ABCB6 shRNA vector (80 μg protein, lane 4). β-actin is shown for 
loading control132. B ABCB6 confers cadmium resistance in SNB-19 glioblastoma cells. SNB-19 
cells were engineered to silence ABCB6 expression by ABCB6 shRNA (ABCB6 sh) or 
overexpress ABCB6 (ABCB6). As compared to cells expressing a non-target control shRNA 
(Ntrg sh) or a control (empty) vector (Vctr), overexpression of ABCB6 confers cadmium 
resistance, whereas attenuation of ABCB6 levels increases cadmium sensitivity. IC50 values 
represent means of triplicate measurements (see inset)132. 
 
Next, we investigated Cd-toxicity in these characterized constructions. Fit curve 
from cytotoxicity results demonstrated that overexpression of ABCB6 effectively 
increased Cd tolerance of SNB-19 cells, while attenuation of ABCB6 expression 
sensitized SNB-19 cells to Cd (Fig. 20B). We observed significant difference between 
IC50 values of ABCB6 attenuated and overexpressed cell lines. In the case of HeLa cells 






4.1.9. Human ABCB6 localizes to lysosomes of SNB-19 glioblastoma cells  
ABCB6 localization was examined in immunocytochemical experiments by using 
“Lan” OSK43 antibody recognizing an extracellular epitope of the transporter28. Analysis 
of SNB-19 cells by confocal microscopy confirmed the localization of the endogenous 
ABCB6 protein in the lysosomal compartment (labeled by LAMP1), and its absence in 
mitochondria (labeled by AIF). Overexpression of ABCB6 also resulted in 
endolysosomal expression that was clearly distinct from the mitochondrial pattern (Fig. 
21). 
  
Figure 21. ABCB6 is localized in the endolysosomal compartment of SNB-19 cells. 
Subcellular localization of endogenous and overexpressed ABCB6 was revealed by 
immunofluorescence labelling and detected laser-scanning confocal microscopy. Endogenous 
(upper panels) and overexpressed (lower panels) ABCB6 was visualized by using the OSK43 
ABCB6 antibody (green); nuclei were labelled with Hoechst 33342 (blue); organelles were 





4.2. ABCB6 and melanogenesis 
Several ABCB6 mutations are linked to the autosomal dominant pigmentary 
disorder DUH30. Initially, three mutations in the ABCB6 gene were described in DUH 
patients (L356P, S170G, G579E)30. Further variants of ABCB6 involved in DUH were 
identified: A453V, S322K87, S322R, Y424H88 and Q555K and deletion in exon 1, 776 
delC83,91. At present, the mechanism how ABCB6 affects skin pigmentation is not known. 
Therefore in an attempt to understand the link between ABCB6 mutations and the DUH 
phenotype, we investigated the subcellular localization and function of ABCB6 in a 
human melanocytic cell line, MNT-1148,149. Most of the experimental work was relied on 
the expertise of G. van Niel and his colleagues. 
 
4.2.1. ABCB6 localizes to early melanosomes and lysosomes in the human 
melanocytic cell line MNT-1  
To investigate the localization of ABCB6 in MNT-1 cells, specific intracellular 
markers were used, while ABCB6 was labeled by the OSK43 antibody. Confocal 
microscopic analysis was made by N. Kucsma and J. M. Reisecker. Images confirmed 
that signal of mitochondria (AIF), ER (Calnexin) or Golgi (RCAS1) did not overlap with 
the signal of ABCB6 (Fig. 22A). But lysosomal compartments (LAMP1) and mainly 
early (stage II) melanosome markers (NKI-beteb and HMB45) showed colocalization 
with ABCB6. NKI-beteb and HMB45 antibodies recognize insoluble protofibrils and 
fibrils of PMEL. Earlier or even later forms of melanosomes did not contain appreciable 
ABCB6 levels. This suggests that ABCB6 is specifically associated with maturing 






Figure 22. Determination of the subcellular localization of ABCB6 in MNT-1 cells. A 
Expression of the endogenous ABCB6 protein was visualized by the OSK43 ABCB6 antibody 
(green); nuclei were labeled with Hoechst 33342 (blue); and organelles were labeled with specific 
markers (red): ER (Calnexin), Golgi (RCAS1), mitochondria (AIF), early endosomes (EEA1), 
lysosomes (LAMP1). Non-pigmented melanosomes were labeled using an antibody directed 
against the luminal domain of PMEL (NKI-beteb) and HMB45; pigmented melanosomes were 
stained with TRP-1. Immunostaining and laser-scanning confocal microscope was used. The scale 





Intracellular distribution of ABCB6 was examined by using electron microscopy 
also. Imaging and analysis of EM images were made by P. Bergam in CRNS, Paris. 
Immunogold labeling of ultrathin cryosections of MNT-1 cells showed another evidence 
for enrichment of ABCB6 in stage II melanosomes. The transporter localized in tubulo-
vesicular structures containing dense material that we identified as lysosomes (Fig. 23). 
These approaches have led us to conclude that endogenous ABCB6 is localized to 
lysosomes and early melanosomes. This expression pattern is exactly at the crossroad 
between the endo-lysosomal and the melanosomal biogenesis pathways where PMEL 
fibril formation is initiated150. 
 
Figure 23. Localization of ABCB6 on ultrathin cryosections of MNT-1 cells. Cells were 
double immunogold labeled for PMEL luminal domain (NKI-beteb, PAG10 nm) and ABCB6 
(PAG15 nm). A Arrows indicate colocalization of endogenous ABCB6 and PMEL in non-
pigmented melanosomes. The scale bar represents 500 nm. B Asterisks show ABCB6 in 
lysosomal tubulovesicular structures. The scale bar represents 200 nm. Mitochondria are 
annotated with “m.” C Quantification of immunogold labeling of endogenous ABCB6 inMNT-1 
cells. Gold particles representing labeling for ABCB6 in the EM analysis were counted and 
assigned to the indicated compartments, which were identified based on morphology (MVB - 






4.2.2. Downregulation of ABCB6 by siRNA perturbs early steps of PMEL 
amyloid formation without eliminating melanogenesis  
In the next step we tried to unravel the functional relevance of ABCB6 in 
melanocytes. We were curious about how the elimination of ABCB6 will affect the 
pathway of melanogenesis. We didn’t expect that the whole machinery will collapse 
without the transporter, since pigmentation disorders were not manifested even in ABCB6 
KO mice45,72. Additionally, Lan (-) patients did not show pathologic pigmentation 
symptoms28,80. First, specific siRNA constructs were tested for attenuation of ABCB6 
(Fig. 24A). Melanin contents were measured in ABCB6 attenuated cells, but significant 
alteration was not detected (Fig. 24B). 
 
 
Figure 24. Effect of ABCB6 depletion on melanogenesis. A Downregulation of ABCB6 in 
MNT-1 cells. Immunoblot analysis of whole cell lysates isolated from MNT-1 cells treated with 
control or anti-ABCB6 siRNA constructs. Tubulin is shown for loading control. B Effect of 
ABCB6 depletion on the intracellular melanin content of MNT-1 cells. Values show averaged 
melanin levels obtained after treatment with 6 different siRNA constructs (MNT-1 siABCB6), 
relative to control (siCtrl)130. 
 
Confocal and electron microscopic results about the localization of ABCB6 
suggested that the protein can affect the early steps of melanogenesis. Trafficking of 
melanosomal proteins (PMEL, TRP-1) into their respective melanosomal compartments 
were investigated, which is a crucial task during melanogenesis. During normal 
melanosomal maturation, PMEL is targeted to early melanosomes where it generates 
amyloid fibrils. Further steps include targeting of TRP-1 and other melanogenic enzymes 
to late stage melanosomes allowing the production of melanin that covers PMEL fibrils 




images showed separated PMEL-positive (NKI-beteb, red) and TRP-1-positive (TRP-1, 
green) compartments (Fig. 25).  
 
 
Figure 25. Downregulation of ABCB6 does not influence trafficking of melanosomal 
proteins. Subcellular localization of melanosomes was followed by confocal microscopy; using 
antibodies labeling early (NKI-beteb for PMEL, red) and late melanosomes (TRP-1, green). 
Nuclei are stained with DAPI (blue)130. 
 
Formation of PMEL-derived fibrils requires the sequential maturation of PMEL 
protein115,117. Analysis of PMEL amyloid matrix formation in MNT-1 cells by EM 
showed that abolishment of ABCB6 expression did not change the global ratio between 
pigmented and unpigmented melanosomes or the number of lysosomes (Fig. 26). 
However, loss of ABCB6 resulted in a significant decrease in the number of early 
melanosomes displaying normal PMEL fibril formation (Fig. 26B). Remarkable large 
aggregates filled the lumen of early and late melanosomes, identified by the presence of 
clathrin coats and melanized fibrils (Fig. 26A inset). These aggregates were slightly 
similar to lysosomal storage disorder structures such as ceroid lipofuscinosis151 but with 
a more complex, hydrangea-like structure suggestive of lipid–protein complexes. These 
results showed that depletion of ABCB6 somehow modified PMEL fibril formation 




   
Figure 26. Representative ultrathin section images of control and ABCB6 depleted MNT-1 
cells embedded in resin. A Black arrowheads indicate stage I melanosomes, and white 
arrowheads point to mature melanosomes containing PMEL fibrils covered by melanin. White 
arrows point to aberrant melanosomes containing a “hydrangea-like” structure (enlarged in the 
inset). The scale bar represents 1 μm. B Quantification of endosomal/melanosomal compartments, 
as defined by the morphology of the organelles in conventional EM of control or ABCB6-depleted 
MNT-1. Values represent the percentage of each compartment relative to all of the 
endosomal/melanosomal compartments identified in 20 cell profiles per condition. p Values: * 
p<0.05, ** p<0.02, *** p<0.01130. 
 
4.2.3. ABCB6 mutations prevent the rescue of normal amyloid fibril 
formation  
In former experiments we saw that downregulation of ABCB6 caused perturbation 
at the early steps (stage II) of melanosome formation (Fig. 26) suggesting that some of 
the early step needed the function of ABCB6. So, we had the experimental setup in MNT-
1 cells, where ABCB6 attenuation caused abnormal melanosomes. To enlighten the effect 
of ABCB6 in this process we attempted to rescue the abnormal phenotype with ABCB6 
variants.  
MNT-1 parental cells were transfected with ABCB6 variants: wild-type (WT), the 
inactive (K629M)24 or a DUH mutant (G579E) variant152. Their localization was also 




an antibody directed against the luminal domain of PMEL (NKI-beteb and HMB45), 
while pigmented melanosomes were stained with TRP-1. Overall, mutants (K629M, 
G579E) displayed a similar localization pattern to the endogenous ABCB6 protein, 
although the association of the DUH mutant variant with markers of the amyloidogenic 
luminal domain of PMEL and the PMEL fibrils was less pronounced (HMB45 and NKI-
beteb) (Fig. 27, Fig. S2). Different staining pattern could indicate that PMEL luminal 
fragments were produced but their aggregation into fibrils might have been affected. 
 
 
Figure 27. Localization of ABCB6 variants in MNT-1 cells. Pearson's correlation coefficients 
for colocalization of ABCB6 variants with the organelle-specific markers. (For confocal 
microscopic images see Fig. S2) Expression of WT (ABCB6 WT), and mutant ABCB6 variants 
(ABCB6 K629M and ABCB6 G579E) was visualized in MNT-1 cells using the OSK ABCB6 
antibody, nuclei were labeled with Hoechst 33342; and organelles were labeled with specific 
markers: ER (Calnexin), Golgi (RCAS1), mitochondria (AIF), early endosomes (EEA1), 
lysosomes (LAMP1). Non-pigmented melanosomes were labeled using an antibody directed 
against the luminal domain of PMEL (NKI-beteb and HMB45); pigmented melanosomes were 
stained with TRP-1 (red). Colocalization analysis was performed with ImageJ (National Institute 
of Health) using the JACoP v2.0 plugin. The scale bar represents 10 μm130. 
  
In further experiments, melanoma cells stably expressing ABCB6 variants were 
depleted for endogenous ABCB6 using the siRNA construct targeting non-coding region 
of the gene (Fig. 24A siABCB6#2). Elimination of endogenous ABCB6 protein allowed 
the overexpression of the different ABCB6 variants thereby their effect could be tested 
(Fig. 28A). ABCB6 protein of parental cell line was also silenced by siRNA, like 




melanogenic enzyme TRP-1 revealed normal localization of both proteins (Fig. 28B), 




Figure 28. Overexpression of ABCB6 variants does not influence trafficking of melanosomal 
proteins. A Immunoblot analysis of whole cell lysates from parental MNT-1 cells (Parent), MNT-
1 cells overexpressing WT ABCB6 (ABCB6 WT), a catalytically inactivate form of ABCB6 
(ABCB6 K629M) or a DUH mutant variant (ABCB6 G579E). Cells were either treated with 
control or anti-ABCB6 siRNA (No. 2) constructs. Tubulin is shown for loading control. B 
Localization of ABCB6 variants and the melanosomal proteins. Subcellular localization of 
melanosomes was followed by confocal microscopy using antibodies labeling early (NKI-beteb, 
red) and late melanosomes (TRP-1, green). Nuclei are stained with DAPI (blue)130. 
 
In previous experiments, the collaborator group showed that depletion of ABCB6 
by siRNA impaired PMEL amyloidogenesis in early melanosomes and induced aberrant 
accumulation of multilamellar aggregates in pigmented melanosomes. Ultrathin cryo-
sections of MNT-1 cells immunogold labeled for ABCB6 and the PMEL amyloidogenic 
domain, showed enrichment of WT ABCB6 in early melanosomes, as shown for the 
endogenous protein (Fig. 29A left panel). Both mutants were localized to PMEL-positive 
endocytic structures and lysosomes confirming that these mutations did not affect their 
intracellular trafficking. In the case of (K629M), stage II melanosomes contained 
unstructured aggregates of various size, staining positive for PMEL luminal domain (Fig. 
29A, middle panel). When the DUH mutant (G579E) was expressed, endosomal 




positive for the PMEL luminal domain (Fig. 29A, right panel). Morphological analysis of 
ultrathin sections of resin-embedded MNT-1 cells revealed that expression of WT 
ABCB6 restored the number and morphology of stage II melanosomes, suggesting the 
rescue of PMEL fibril formation (Fig. 29B left panel and C). At the same time, 
overexpression of WT ABCB6 resulted in a significant increase of the number of 
lysosomes (Fig. 29C). Notably, lamellar and multilamellar structures could be also 
observed in a minor fraction of early and mature melanosomes (Fig. 29B, left panel inset). 
In contrast, accumulation of aberrant early melanosomes and a decrease of pigmented 
melanosomes were observed on ultrathin cryosections of cells expressing mutant variants. 
Ultrathin sections of resin embedded MNT-1 cells overexpressing the K629M mutant 
confirmed a complete disorganization of PMEL fibrils in these melanosomes (Fig. 29B, 
middle panel, and Fig. 29C). K629M mutant induced the generation and accumulation of 
aberrant compartments, (Fig. 29B, middle panel inset) but devoid of the hydrangea-like 
structures observed in the siABCB6 condition. In the other case similar anomaly was 
observed. Expression of DUH mutant G579E also caused impaired fibril formation and 
showed accumulation of aberrant early and to a less extent late melanosomes. These 
melanosomes contained intraluminal multilamellar structures, as observed in cells 
overexpressing WT ABCB6, and hydrangea-like structures, as observed in ABCB6-
depleted cells (Fig. 29B, right panel inset). These results clearly showed that in contrast 
to the WT protein, the mutant ABCB6 variants were unable to rescue PMEL fibril 
formation. Mutant variants failed to restore the number of normal early melanosomes 
depleted by the downregulation of ABCB6 and inducing instead an accumulation of 
aberrant stage II melanosomes showing signs of improper PMEL fibril formation. 
 





Figure 29. Overexpression of DUH mutant ABCB6 fails to rescue the ABCB6 depleted 
phenotype. A Ultrathin cryosections of MNT-1 cells overexpressing ABCB6 WT (left panel), 
inactive ABCB6 (middle panel) or the DUH variant (right panel) were double immunogold 
labeled for PMEL luminal domain (PAG 10 nm) and ABCB6 (PAG15 nm). Arrowheads indicate 
colocalization of ABCB6 and PMEL in non-pigmented melanosomes. Mitochondria are 
annotated with “m”. The scale bar represents 500 nm. B Representative ultrathin section images 
of resin-embedded control and ABCB6-depleted MNT-1 cells and MNT-1 cells overexpressing 
WT ABCB6 (lower left panel), inactive ABCB6 (lower middle panel) or the DUH variant (lower 
right panel). Melanosome stages are annotated from I to IV; black flowers indicate aberrant 
pigmented melanosomes containing unstructured aggregates along with melanized fibers. White 
stars indicate aberrant lysosomal structures. LD, lipid droplet; V, vacuole; Lys, lysosome; M, 
mitochondria. Scale bar is 200 nm. C Quantification of endosomal/melanosomal compartments 
as defined by the morphology of the organelles in conventional EM of control or ABCB6-depleted 
MNT-1 with or without the overexpression of WT (ABCB6 WT) or mutant ABCB6 variants 
(ABCB6 K629M, ABCB6 G579E). Values represent the percentage of each compartment relative 
to all endosomal/melanosomal compartments identified in 20 cell profiles per condition. p Values: 
* p<0.05, ** p<0.02, *** p<0.01130. Imaging and analysis of EM images were made by P. Bergam 




4.3. MNT-1 cell lines genome edited by CRISPR/Cas9 
In case of a protein, especially in case of a membrane transporter, determination of 
its localization is indispensable. When the adequate membrane compartment is known, 
we can establish our hypothesis about its substrate. It is particularly true in the case of 
ABCB6 since its localization is still a matter of debate. Most studies were based on the 
overexpression of ABCB6, which is always prone to artefacts. That’s why we wanted to 
detect the intracellular distribution of ABCB6 using the latest gene editing method. 
 
4.3.1. Cytogenetic analysis of MNT-1 cells 
Before starting genetic modification on a cell line, we have to be aware of the copy 
number of the gene of interest. Especially cancer cell lines have often abnormal, polyploid 
chromosome assemblies. Cytogenetic analysis was performed to determine chromosome 
assembly of MNT-1 cells. Analysis revealed that MNT-1 cells have complex karyotype 
(hyperdiploid), generally cells have 63-66 chromosomes. Fluorescent in situ 
hybridization (FISH) provides a powerful tool for identifying the location of a DNA 
sequence and quantitative differences, like copy number variations on metaphase 
chromosomes. Since ABCB6 was mapped to chromosome 2q35, control FISH probe 
indicated chromosomes II (green centromeres). It appeared that red signals of ABCB6 
were observed on chromosomes II and one of the extra locuses was localized at the end 
of a chromosome and the other at the middle of another chromosome (Fig. 30A,B). These 
results indicated that MNT-1 cells have four ABCB6 alleles. Analysis was performed by 





Figure 30. FISH analysis of DAPI stained nucleus of MNT-1 cells. A Inter- and B metaphase 
cells were imaged. Control probe labelled chromosomes II centromeres (green), ABCB6 specific 
probe labeled alleles containing ABCB6 (red). There were two chromosomes II and ABCB6 was 
located to them, plus there were two chromosomes, which were labeled ABCB6, but have no 
centromere II (unpublished data).  
 
4.3.2. Endogenous ABCB6 is located to lysosomes 
Using the latest and most efficient genome editing method, the CRISPR/Cas9, we 
aimed to modify ABCB6 gene in MNT-1 cells. The work was done in cooperation with 
P. Kulcsár (EI RCNS, HAS). GFP label by genome editing can reveal the authentic 
location of a native protein, in contrast of examination of an artificially overexpressed 
and tagged protein. Thus, in our first engineered cell line, to monitor the physiological 
localization of the protein, the ABCB6 gene was endogenously fused with GFP coding 
sequence. For this genetic modification 3 plasmids were used: the first contained the GFP 
coding sequence between the ABCB6 homologue arms (~1000 bp each), the second 
contained the SpCas9 expression cassette and the third contained the guide RNA 
sequence with the spacer, which targets ABCB6 (Table S2). Cells successfully transfected 
with all the three plasmids and SpCas9 caused DSB, HDR could be used to modify the 
genome of MNT-1 cells. In every case of genetic modification, we chose several possible 
target sequences with the WGE web tool (https://www.sanger.ac.uk/science/tools/wge). 
Applying endogenous GFP tag we had to design the spacer sequences (Table S2), so that 
the GFP insertion is in frame with last exon of ABCB6 (Fig 31A).  
Transfected cells were analyzed 8-days post-transfection (no background signal 
from plasmid can be detected anymore) and cells were sorted by FACS for GFP and 
cloned on 96 well plates. We detected single cell clones using Calcein AM and a High 
Content Screening device. Single cell clones created by different spacer sequences were 
grown then tested and selected with the following methods. First, we confirmed the GFP 
positive population by flow cytometry. Integrated GFP sequence was validated by PCR 
on genomic DNA extract with two different primer pairs (Fig. 31A). Clones where 
integration happened, specific bands were detected at 1500 bp (Fig. 31B) or 1200 bp (Fig. 
31C). PCR results suggested that on some alleles, the original sequence remained intact 
(Fig. 31B). Thus, we investigated non-tagged (original) and GFP-tagged (CRISPR) 
modified ABCB6 by immunoblot (Fig. 32D). Interestingly, clones generated by spacer 




that the homologous arms mediated GFP insertion occurred. But it was revealed that in 
clones created with spacer #1, indel mutations caused frameshift in the coding sequence 
eliminating the STOP codon. We presumed that the translated mutant protein was 
unstable, and it was degraded by the proteasomal machinery and it could not be detected 
on immunoblot (Fig. 31D). But to sum up, we created endogenously GFP labeled 
melanoma cell lines. 
 
 
Figure 31. Single cell clones modified with CRISPR/Cas9 system were selected by different 
methods. A Schematic representation of ABCB6 gene modification by homology directed repair 




ABCB6 gene, green - GFP sequence, light blue - homology arms (HA), red - stop codon, dark 
grey - 3’ untranslated region (UTR), yellow - target site with PAM motif, scissor - double strand 
brake caused by Cas9 endonuclease. Two primer pairs were designed for PCR reactions (pink and 
purple arrows) B PCR reactions were run on extracted genomic DNA and PCR products were 
separated on agarose gel. Insertion of GFP coding sequence was detected with the first primer 
pair at 1500 bp, original genomic sequence was detected at 700 bp (pink arrows). C The position 
of the integrated GFP coding sequence was detected with the second primer pair (purple arrow) 
(unpublished data). D Immunoblot of three selected MNT-1 clones using anti-ABCB6 antibody 
ABCB6-567139. Samples were taken at two separate time points (t1 and t2). The molecular weight 
of wild type ABCB6 is 97 kDa, while the tagged transporter is about 125 kDa (unpublished data). 
 
Figure 32 shows tagged ABCB6 localization in the selected clone MNT-1/1A. It is 
consistent with the overexpressing systems, ABCB6 colocalizes with the lysosomal 
marker (LysoTracker) and do not with mitochondrial marker. Images were obtained by J. 
M. Reisecker (MedUniWien). 
 
 
Figure 32. Endogenous ABCB6-GFP localizes to lysosomes in MNT-1 cells. ABCB6 signal 
(green) colocalized with red lysosomal marker (LysoTracker). Nucleuses were stained with 
DAPI. Scale bar 20 µm (unpublished data). 
 
With this setup, we can only detect a steady-state condition of ABCB6. To expand 
our possibilities, in the next experiment, we used the RUSH system. RUSH is a two-state 
assay based on the reversible interaction of a hook protein in a donor compartment and 
the protein of interest. The hook protein is fused to streptavidin and stably anchored and 
the reporter protein is fused to streptavidin-binding peptide (SBP). Biotin addition causes 
a synchronous release of the reporter from the hook153. Another tag was cloned into the 
earlier used pCDNA3 plasmid. Between the HR arms, upstream to GFP, a Streptavidin-
binding peptide (SBP) coding sequence was fused (Fig. 33A), which allows to arrest our 
transporter at the preferred intracellular compartment (i.e. ER). In the planned 





Figure 33. The selected clone, MNT-1/R251 carries four ABCB6-SBP-GFP alleles. A 
Schematic representation of ABCB6 gene modification by homology directed repair and 
CRISPR/Cas9 system. Dark orange - first methionine encoded by ATG, grey - exons of ABCB6 
gene, light orange - streptavidin binding protein (SBP), green - GFP sequence, light blue - 
homology arms (HA), red - stop codon, dark grey - 3’ untranslated region (UTR), yellow - target 
site with PAM motif, scissor - double strand brake caused by Cas9 endonuclease. B Immunoblot 
analysis of modified MNT-1 clones using anti-ABCB6 antibody ABCB6-567139. The molecular 
weight of wild type ABCB6 is 97 kDa, while the tagged transporter is about 125 kDa.  
C Real-time PCR quantification of GFP copy number in modified MNT-1 clones. For reference 
HEK293 cell clones were used bearing 1, 4 or 7 copies of RPPH1. Different RUSH-GFP clones 
named MNT-1/R. MNT-1/3E was a selected clone from the former experiment, expressing 
endogenously tagged ABCB6-GFP. Data were analyzed by the StepOne 2.1 software, using the 




The “hook” CD74 protein fused to streptavidin contains an ER retention signal 
sequence will function as a transmembrane protein which will anchor the SBP-GFP 
tagged ABCB6. Biotin addition will release ABCB6 and we can monitor the intracellular 
route of the transporter. In preliminary experiments, without expressing the hook protein, 
ABCB6-SBP-GFP and the endogenous ABCB6-GFP or overexpressed constructs 
showed identical localization. Applying real-time PCR, immunoblot and Sanger 
sequencing we identified a clone (MNT-1/R251) which carries the designed modification 
in all alleles (Fig. 33B). From the former experiment MNT-1/3E cells (ABCB6-GFP) 
were also tested and we assumed that the clone has two GFP tagged and two unmodified 
alleles. Trafficking of ABCB6 after biotin addition will be examined by confocal 
microscopy. 
 
4.3.3. ABCB6 KO cell line 
Taking advantage of the fact that we had a cell line expressing GFP tagged ABCB6 
in each chromosome, in the next step we wanted to create an ABCB6 knockout (ABCB6 
KO) cell line. It was straightforward to detect the abolishment of GFP signal by FACS. 
The first exon of ABCB6 was targeted and we chose several target sequences (Table S2). 
After DSB caused by RNA directed SpCas9, we wanted to integrate another selection 
marker, so we used NHEJ mechanism of the cells. Self-cleaving pCMV-tagBFP plasmid 
was co-transfected, which contained its own spacer sequence, thus the plasmid can cleave 
and linearize itself in the cell, thereby enhancing the integration of BFP selection 
cassette154 (Fig. 34A). 
 After transfection, cells could be sorted by flow cytometry based on their 
fluorescence, selected cells were GFP negative, but BFP positive. Single cell cloning was 
evaluated as described in the Methods. Lack of ABCB6 expression was confirmed by 
immunoblot (Fig. 34B), confocal microscopy (Fig. 35) and results were verified in 
genomic level using PCR and Sanger sequencing. Based on immunoblotting results 
ABCB6 KO 32, 33 and 13 clones were not knockouts, but the rest of the clones did not 
express WT or SBP-GFP tagged ABCB6 (Fig. 35B, 36). To investigate the function of 
ABCB6 in pigmentation was a straightforward step to measure the melanin content of 
knockout clones. We chose several clones, but we detected variable melanin levels (Fig. 




but since then this kind of difference was not observed. These experiments did not reveal 
the physiological function as yet, further studies are needed. First, we intend to analyze 
morphology of ABCB6 KO cells by electron microscopy as ABCB6 attenuated cells.  
 
   
Figure 34. Creation of ABCB6 knockout cell line A Schematic figure of creation of ABCB6 
KO cell line by CRISPR/Cas9. Dark orange - first methionine encoded by ATG, grey - exons of 
ABCB6 gene, light orange - streptavidin binding protein (SBP), green - GFP sequence, red - stop 
codon, dark grey - 3’ untranslated region (UTR), yellow - target site with PAM motif, scissor - 
double strand brake caused by Cas9 endonuclease, CMV-BFP-polyA shows the blue fluorescent 
protein expression cassette. B Immunoblot analysis of MNT-1 modified cell clones. Expression 
of ABCB6 from total MNT-1 cell lysates was monitored by immunoblotting, using the anti-
ABCB6 antibody ABCB6-567139. Clones were made by different spacer sequences. Molecular 
weight of WT ABCB6 is 97 kDa (MNT-1 parent), while the tagged transporter was about 125 






Figure 35. Confocal microscopy analysis of MNT-1 modified clones. After DSB in the first 
exon of ABCB6 caused by RNA directed SpCas9, a selection marker, BFP (blue), integrated in 
the genome. Parental cells do not express fluorescent protein, MNT-1/R251 cells are GFP positive 









Figure 36. Effect of knockout of ABCB6 on the intracellular melanin content of MNT-1 
cells. For determination of melanin content, cells were washed with PBS and dissolved in 250 μl 









At present, the subcellular localization of ABCB6 remains a matter of debate. In 
2006, ABCB6 was described as a mitochondrial porphyrin transporter, located to the 
outer mitochondrial membrane. Krishnamurthy and his colleagues concluded that the 
protein is a coproporphyrinogen III importer thus regulator of erythroid maturation and 
hem synthesis 25. Subsequent studies have found ABCB6 to be dispensable for 
erythropoiesis, and located the protein to the surface of red blood cells 24,28, suggesting 
that mitochondrial porphyrin import may not depend on ABCB6. The research of K. Kiss 
fundamentally questioned statements in the literature and raised new insights about the 
physiological role of ABCB6. Results of our laboratory clearly corroborate the 
extramitochondrial localization of ABCB6 24,67. Further, ABCB6 was detected in the 
plasma membrane of cells 63, and throughout the endolysosomal continuum 56,64,155,156. 
These findings challenged the paradigm linking the expression and function of ABCB6 
to mitochondria. However, the physiological function of ABCB6 in the endolysosomal 
compartment has remained elusive. Therefore, in the presented work we investigated 
ABCB6 in different model systems to identify lysosome related functions. 
 
5.1. The role of ABCB6 in Cd detoxification 
S. pombe and C. elegans are important models for elucidating conserved pathways 
and processes relevant to human biology and disease. Even though this ‘orthologue-
function conjecture’ has many known exceptions, it remains a valuable and widely used 
method for predicting gene functions based on sequence similarity. In particular, rescue 
of mutant phenotypes has established the function of several orthologous human proteins. 
It is assumed that such orthologous gene pairs share at least some aspects of their 
characteristics. Yeast and humans are separated by a billion years of evolution157, yet 
there are thousands of recognizable orthologs between the two species. Moreover, there 
are hundreds of genes from one species that can functionally replace (complement) their 
orthologues in the other158. The high degree of sequence and topological similarity 
between the HMT-1 proteins and ABCB6 suggested an evolutionary conserved, 




Organisms have evolved several mechanisms to detoxify or eliminate harmful 
heavy metals such as Cd159. Cadmium can mainly be found in the earth's crust; it always 
occurs in combination with zinc. Cadmium also consists in the industries as an inevitable 
by-product of zinc, lead and copper extraction and about three-fourths of cadmium 
production is used in Ni-Cd batteries160. It is also found in manures and pesticides, thus 
causing soil contamination161. Since it can accumulate in aquatic organisms and 
agricultural crops, animals are primarily exposed to cadmium through food or water162–
165. In addition, humans are exposed to Cd pollution due to smoking tobacco products166. 
The major toxic form of Cd in eukaryotic cells is the Cd2+ ion. Although Cd2+ is not a 
Fenton metal and therefore is not capable of exerting redox reactions in biological 
systems, it may induce formation of reactive oxygen species (ROS) by depletion of 
endogenous redox scavengers, inhibition of antioxidative enzymes, inhibition of the 
mitochondrial electron transport chain, and/or displacement of redox active metals, such 
as Fe2+ or Cu2+, from their carrier proteins and thereby cause mitochondrial damage and 
trigger apoptosis, to name few of the mechanisms underlying Cd2+ toxicity. Cd2+ can also 
substitute for Ca2+ in cellular signaling or for Zn2+ in many enzymes and transcription 
factors which may lead to cellular dysfunction. Organisms have evolved distinct 
mechanisms to detoxify and eliminate cadmium from the cells167. Animals and fungi 
produce metallothioneins (MTs), a class of low molecular weight (500–1400 Da), 
proteins located in Golgi apparatus168. These proteins are involved in responses to both 
xenobiotic heavy metals, such as mercury, cadmium, arsenic, as well as physiological 
ones, such as selenium (Se), copper, zinc, etc.168. Moreover, MTs were shown to be 
beneficial in controlling oxidative stress via capturing destructive free radicals169. Among 
the non-enzymatic antioxidants, glutathione (GSH; γ-glutamyl-cysteinyl-glycine) is a low 
molecular weight, water soluble thiol compound. Apart from the role in storage and 
transport of reduced sulfur, GSH is a common chelator involved in cellular response, 
transport and excretion of metal cations. In Saccharomyces cerevisiae, sequestration of 
cadmium–glutathione complexes is mediated by ScYCF1, which belongs to the ABCC 
subfamily170. Another major function of GSH is the formation of phytochelatins (PCs) 
that bind heavy metals for safe transport and sequestration in plant cells. Thus, GSH plays 
a vital role in detoxifying toxic metals/metalloids and xenobiotics171. In addition to plants, 




proteins of S. pombe and C. elegans confer cadmium resistance by sequestrating Cd–
phytochelatin complexes102,105. RNA interference analyses revealed, however, that ce-
hmt-1-deficient worms were significantly more sensitive to cadmium than ce-pcs-
deficient worms. In addition, morphological differences were observed between the two 
RNAi treated lines upon exposure to Cd. The intestinal cells of the progeny of ce-pcs-1-
RNAi worms underwent necrosis, while the same cells in the progeny of ce-hmt-1-
injected worms generated spherical refractive inclusions106. Further investigation of hmt-
1 and pcs-1 revealed that these genes are expressed in different cell types but are co-
expressed in coelomocytes of the worms. Cytotoxicity studies with knock out worms 
implied that CeHMT-1 also confers tolerance to As and Cu, and the transporter and PC 
synthase do not function in a simple linear pathway. Moreover, substrates of HMT-1 are 
not limited to Cd-PC complexes104. In addition, DmHMT-1 from the non-PC producing 
fruit fly was able to rescue the Cd-sensitivity of the S. pombe hmt-1 mutant101. 
Conversely, SpHMT-1 conferred tolerance to Cd in Escherichia coli and Saccharomyces 
cerevisiae, organisms devoid of phytochelatins103. Furthermore, data showed that S. 
pombe hmt-1 mutant accumulates significant levels of PCs in vacuoles101, suggesting that 
other proteins may contribute to PC transport into the vacuoles. Mendoza-Cózatl and his 
colleagues performed systematic analysis of different Abc genes in fission yeast. Using 
the hmt-1-deleted background identified a full-size ABCC type transporter, SpAbc2, 
which was also a key factor of Cd tolerance. Complementation experiments were 
performed to identify the substrate specificity of the proteins. Testing different 
combination of mutants, authors noticed that both SpAbc2 and HMT-1 mediated the 
accumulation of PCs in the vacuoles. Furthermore treatment of mutant strains with a 
fluorescent glutathione conjugate showed that HMT-1 was also capable of transporting 
GSH complexes172. 
Investigating S. pombe model cells we showed that heterologous expression of 
ABCB6 rescues the Cd-sensitive phenotype of HMT-1 deficient strain (Fig. 10) and the 
protein was detected in the vacuolar membrane of S. pombe cells (Fig. 9). Measurement 
of vacuolar Cd content by GFAAS showed Cd accumulation in vacuoles of hmt-1 deleted 
strain expressing ABCB6. This indicates that the rescue of HMT-1 deficient yeast cells 
was based on the vacuolar sequestration of cadmium. This cytotoxicity setup can be used 




absence of the protein in humans or mice does not lead any obvious phenotype. Although 
mutations cause abnormal phenotype or lower expression levels in patients (DUH, 
Coloboma, FP, Lan). The following set of mutant variants of ABCB6 were successfully 
expressed in S. pombe cells: A57T (Col), S170G (DUH), R192Q (Lan), R192W (Lan), 
R276W (Lan), G588S (Lan), V609M (Lan), R638C (Lan) (Fig. 11A). Only two of the 
mutations, R192W and R276W failed to cause Cd tolerance (Fig. 11B). In the other cases 
mutant ABCB6 behaved similar to wild type protein. In Hela cells R192Q and G588S 
mutations did not change the intracellular expression pattern of ABCB6, while R192W 
showed ER retention29, which can explain the malfunction in yeast cells. In spite of this, 
R276W caused no alteration of expression or cellular localization of ABCB6 in HEK-
293 cells. But measurement of cation flux demonstrated greater loss of potassium or 
rubidium ions from cells expressing R276W mutant protein.173. In all examined 
organisms, overexpression of SpHMT-1 conferred tolerance only to Cd103, whereas 
substrates of CeHMT-1 also include As(III) and Cu(II)106. In fission yeast, ABCB6 
conferred resistance to Cd(II), As(III), but not to As(V), Hg(II) or Cu(II) (Fig 12). 
Encouraged by the results in fission yeast we performed cytotoxicity experiments 
with the nematode C. elegans to test the rescue effect of ABCB6 in a multicellular 
organism. Similar to S. pombe, human ABCB6 provided protection to hmt-1 deleted 
animals against Cd toxicity. In C. elegans, ABCB6 was expressed under the control of 
endogenous CeHMT-1 promoter. This offered an opportunity to study ABCB6 
localization in an intact organism without the burden of artifacts associated with 
overexpression. Co-expression of ABCB6 and CeHMT-1 showed colocalization, 
although maybe the same promoter led to the similar expression pattern (Fig. 17). Further 
experiments specifying intracellular organelles showed that CeHMT-1 is localized to the 
endosomal compartment, mainly to the apical recycling endosomes in the intestinal cells 
of the nematode (Fig. 19). This result was in complete agreement with a recent report95, 
and importantly, ABCB6 was found in the same intracellular compartments (Fig. 19). 
Similar to ABCB667, CeHMT-1 lacking the NTE domain was targeted to the plasma 
membrane, and the truncated form of CeHMT-1 did not confer tolerance to Cd95. 
Determining the subcellular localization of a protein is a key step toward 
understanding its cellular function. Although we found that the endogenous ABCB6 




21), and it plays a role in Cd detoxification (Fig. 20), it is difficult to imagine that 
mammalian cells would be exposed to such high level of Cd contamination. Given the 
conservation of HMT-1 proteins, we suggest that the ABCB6-mediated increase of 
vacuolar cadmium levels shown in Fig. 14 can be explained by the direct transport of 
(Cd–GS2) complexes. It was shown that HMT-1s are able to detoxify Cd without PCs. 
SpHMT-1 overexpression in E. coli enhanced the Cd tolerance and DmHMT-1 
overexpression in S. pombe suppressed the Cd sensitivity hmt-1 mutants. Moreover, 
DmHMT-1 expressed in S. pombe cells was located to the vacuolar membrane but did not 
transport Cd-PC complexes134. We assume that it might be an evolutionary conserved 
mechanism and the real function is not revealed yet, may be transport of some other kind 
of metal-conjugates can be relevant in mammalian cells. 
Overall, our laboratory showed that ABCB6 localizes to the same intracellular 
compartment as SpHMT-1 and CeHMT-1, performing an overlapping function linked to 
the intracellular sequestration of metal complexes. The finding that the monoclonal anti-
ABCB6 antibody could recognize the yeast transporter (Fig. 8B) strengthened the 
similarity between HMT-1 and ABCB6. First, we showed that ABCB6 rescues the Cd-
sensitive phenotype of HMT-1-deficient S. pombe and C. elegans strains (Fig. 10,15). 
Second, we revealed that ABCB6 function is required for the sequestration of cadmium 
into HMT-1-deficient yeast vacuoles (Fig. 14) by applying non-functional mutant of 
ABCB6. We mutated the universally conserved lysine residue in the Walker A sequence 
24 which is crucial for nucleotide-binding174. Third, we provided evidence that ABCB6 
localizes to lysosomes of human glioblastoma cells and modulates their cadmium 
sensitivity (Fig. 20). Taken together we had no functional essay before, but now we have 
a rescue model system for the characterization and study of ABCB6.  
It also remains to be determined how the evolutionary conserved role in 
detoxification is manifested in pathological conditions. Genetic studies revealed that 
mutations in ABCB6 can cause several hereditary diseases ranging from 
pseudohyperkalemia81, coloboma75, to dyschromatosis universalis hereditaria 
(DUH)83,87,152. The pathogenic role of ABCB6 in these conditions is not understood, as 
there is no obvious overlap between these phenotypes. Interestingly, the absence of the 
protein in humans or mice does not lead any obvious disorder. In case of ABCB6 knock 




stress factors where ABCB6 function can be clearly beneficial175. It is tempting to 
speculate that maybe impaired transport of glutathione adducts, thereby abnormal 
endolysosomal metal homeostasis can result these phenotypes. The relevance of 
endolysosomal compartment in the intracellular metal homeostasis is well-known176. The 
big question is that why the glioblastoma cells need the ABCB6 provided protection 
against Cd and how their (metal) metabolism differs from other cell lines. 
 
5.2. The role of ABCB6 in pigmentation 
Dyschromatosis Universalis Hereditaria (DUH) is a rare autosomal dominant 
genodermatosis characterized by asymptomatic hyper- and hypo-pigmented macules that 
appear in infancy or early childhood. Etiopathology of DUH is not known. Lesions show 
a focal increase or decrease in melanin and melanosome content of melanocytes and 
keratinocytes of the basal layer, which is believed to be the consequence of a defect in 
melanosome production and/or distribution, rather than a disorder of melanocyte 
numbers177–179. DUH patients with ABCB6 mutations do not exhibit any of the additional 
abnormalities. 
Melanogenesis involves two sequential but independent processes, functional 
amyloid fibril formation and pigment synthesis. Melanosomes are cell type-specific 
lysosome-related organelles, they derive from early endosomes, which are called stage I 
melanosomes in pigment cells. During melanosome biogenesis, stage I melanosomes 
mature into stage II melanosomes which acquire specific identity and morphology 
separate from lysosomal organelles87,111. Stage I melanosomes are characterized by a 
clathrin coat and few intralumenal vesicles180. In their lumen amyloid fibril generation is 
initiated from cleavage products of PMEL, a transmembrane protein expressed in 
melanocytes181. During maturation into stage II melanosomes, the formation of these 
fibrils requires concomitant proteolytic processing of PMEL and differential sorting of 
PMEL cleavage products118,121,182,183 (Fig. 37). PMEL amyloidogenesis is completed in 
ellipsoidal shaped stage II melanosomes where the assembled amyloid lumenal fibrils 
serve as a matrix for pigment deposition in later stage III and IV melanosomes, which 
have acquired melanogenic enzymes180. Interestingly, lysosomes are thought to 




ABCB6 probably have a role in this lysosome related melanogenesis process and 
therefore we investigated melanisation in model cells. 
Regarding melanogenesis, similar to our heterologous model systems (S. pombe 
and C. elegans) we aimed to set up a rescue system in which we can investigate the role 
of ABCB6. The widely used pigmentation model cell line, MNT-1 human melanoma cell 
culture was studied. It has the complete conserved apparatus to produce all melanosome 
stages continuously, from the generation of PMEL amyloid fibrils to the synthesis of 
eumelanin180,185. Several reports have used this cell line to reveal the role of key proteins 
involved in intracellular trafficking118,186, proteolytic cleavage and signaling pathways187 
regulating melanogenesis. As a first step we characterized the localization of endogenous 
ABCB6 in melanoma cells. Consistent with our previous results we corroborated the 
localization of ABCB6 in the endolysosomal continuum24,67. Cell fractionation, confocal 
and electron microscopic analysis revealed that the protein was localized to lysosomes 
and early melanosomes of MNT-1 cells. While ABCB6 is present on exosomes of 
reticulocytes67, it was not observed in the exosome fraction of MNT-1 cells, in line with 
known differences in the sorting mechanisms of melanocytes and reticulocytes188. 
In a first attempt to understand the role of ABCB6 in melanogenesis and why its 
mutations cause abnormal pigmentation, we eliminated the protein from MNT-1 cells. 
The fact that ABCB6 is located to lysosomes and early melanosomes indicated that the 
transporter may manipulate early steps of melanosome biogenesis. Stage I melanosomes 
have been proposed to be the crossroad where melanosomal and endolysosomal pathways 
segregate180. This expression pattern is where PMEL fibril formation is initiated (Fig. 37). 
Depletion of ABCB6 by different siRNA constructs was successful, but it did not change 
the melanin levels significantly. Interestingly, melanin content of the cells was highly 
variable when various siRNA constructs were used (Fig. 24). Nonetheless, it seemed that 
the traffic of melanosomal proteins was not disturbed, PMEL- and TRP-1-positive 
compartments showed separation (Fig. 25). PMEL is targeted to early melanosomes, 
while further steps include TRP-1 is targeted to late stage melanosomes181. However, our 
collaborators investigated the luminal amyloidogenic fragments of PMEL with HMB45 
and I51 antibodies. ABCB6 depletion induced a variable decrease of the steady state 




ABCB6 may affect the generation of amyloidogenic fragments or their aggregation into 
fibrils. 
Modulation of amyloidogenic PMEL fragment levels has been associated with the 
defect of several steps in melanogenesis, including PMEL cleavage180, PMEL sorting118, 
the change of lysosomal protease activity189, or the loss of melanosomal identity190. In all 
of these conditions, the decrease of amyloidogenic PMEL fragment levels was a result of 
disturbed PMEL fibril formation. Strikingly, morphological analysis at the ultrastructural 
level revealed a unique phenotype associated with ABCB6 depletion, confirming a defect 
in fibril formation (Fig. 26). Downregulation of ABCB6 resulted in decreased amyloid 
formation, and the appearance of large aggregates displaying a hydrangea-like 
morphology in early and mature melanosomes (Fig. 26). Based on their morphology, the 
aberrant structures are likely composed of proteo-lipid aggregates, corresponding to the 
unstructured aggregates containing PMEL luminal domain, as observed in electron 
microscopic cryosections (Fig. 26). We used MNT-1 cells with downregulated ABCB6 
background to test the rescue effect of ABCB6 variants. Expression of the wild-type form 
of ABCB6 almost fully eliminated the aberrant structures and restored the normal PMEL 
fibril formation (Fig. 29). Although we observed increased generation of multilamellar 
lysosomal structures. In the next we investigated the effect of disease related mutations 
and non-functional ABCB6 mutant (Walker A K562M) in this model. (Mutation of the 
catalytic Walker A lysine residue is known to impair the function of ABC transporters191. 
Localization experiment in a mouse cell line showed that DUH mutation G579E affects 
a non-conserved amino acid in the cytoplasmic nucleotide binding domain, though it 
causes irregular phenotype152. In this report a mouse melanoma cell line was used (B16-
F1) and the mutant protein showed accumulation in the Golgi. Importantly, in contrast to 
human skin, mice skin does not contain melanocytes, which are only present in hair 
follicles192. Therefore, mice pigmentation may not be relevant for the role of ABCB6 in 
human model MNT-1. In our set up both variants, G579E and K562M were targeted to 
melanosomes, but their association with markers of PMEL amyloidogenic luminal 
domain and PMEL fibrils was less unequivocal. Despite the appropriate intracellular 
localization (Fig. 28) neither the G579E nor the K562M mutant ABCB6 variant was able 
to restore normal biogenesis of PMEL fibrils. The DUH mutant displayed an 




ABCB6-depleted cells (Fig. 29). In contrast, K562M mutant caused the accumulation of 
aberrant compartments full of protofibrils or small aggregates unable to form fully mature 
amyloid fibrils, but devoid of the abnormal structures observed in the case of ABCB6 
depletion (Fig. 29). Overall, both mutations induced the accumulation of unpigmented 
aberrant melanosomes, showing signs of improper fibril formation. The depletion and 
mutation of ABCB6 prevented the normal maturation and organization of the amyloid 
matrix. The defect in amyloid formation observed in ABCB6-depleted MNT-1 cell line 
is contrary to the normal phenotype of ABCB6 knockout mice. We cannot rule out the 
possibility that the mutant transporter may be compensated by other mechanisms as in 
humans, as in mice. But because of the difference mentioned above between human and 
mice epidermis, pigmentation process in MNT-1 cell line and mice skin may not be 
identical. However, in our publication we showed that beneath the normal fur color of 
ABCB6 −/− mice there are subtle but significant differences in the ultrastructure of the 
retinal pigment epithelium (not shown)193. In this special epithelial layer, formation of 
melanosomes is restricted to a brief developmental period194. We speculated that an early 
defect in melanosomal biogenesis impairs the formation or integrity of the organelles in 
ABCB6 knockouts. Similar phenotypes were described in conditions associated with a 
defect in PMEL fibril formation and the aggregation of aberrant and toxic PMEL 
amyloidogenic fragments damaging melanosome integrity195. In PMEL mutant mice 
models the RPE cells have round melanosomes, which indicate a defect in PMEL fibril 
assembly183,196,197. It has been known that characteristic ellipsoidal shape of melanosomes 
is formed by the fibrils197,198. Surprisingly the shape of the remaining melanosomes in the 
RPE of ABCB6 knockout mice was not abnormal. 
Based on the dominant inheritance of DUH152 and the fact that ABCB6 functions 
in homodimers24,25, we considered that the dominant negative effect can be a 
straightforward explanation and DUH mutations interfere with the wild-type allele. The 
DUH G579E mutation did not affect processing of PMEL, or the sorting of its luminal 
domain onto intraluminal vesicles. Rather, the defect seems to be associated with the last 
steps of fibrillation. The critical step may be when amyloidogenic PMEL fragments turn 
into mature fibrils, between stage I melanosomes and stage II melanosomes. At this phase 
PMEL luminal domain accumulate in multivesicular compartments. The aberrant 




luminal domains from the surface of intraluminal vesicles (Fig. 37). The localization of 
ABCB6 in early melanosomes, the variable melanin levels in ABCB6 attenuated cells 
and the morphological discrepancies observed by electron microscopy all point toward a 
defect in early melanogenesis involving PMEL amyloid fibril formation.  
 
 
Figure 37. The putative position of ABCB6 function in PMEL fibril formation in stage I 
melanosomes. PMEL protein domains: signal peptide (SP), N-terminal region (NTR), polycystic 
kidney disease protein-1-like repeat domain (PKD), repeat domain (RPT), kringle-like domain 
(KDL), C-terminal fragment (CTF), intracellular domain (ICD). PMEL processing proteases are 
indicated in red: proprotein convertase (PC), β-site APP-cleaving enzyme 2 (BACE2) and 
presenilin 2 (PSEN2)199. 
 
Similarly to the ABCB6-null phenotype, complete depletion of PMEL has only a 
slight effect on the coat color of mice197, while silver mice expressing a truncated version 
of PMEL are unable to produce a functional matrix195, and BACE2 knock out mice that 
fail to process PMEL183 display a grey coat color. The hypopigmented areas characteristic 
to DUH in humans may result from a defect in the maturation of early melanosomes or 
from the compromised integrity of pigmented melanosomes due to the accumulation of 
PMEL toxic oligomers200. 
In melanoma cells overexpressing wild type ABCB6 the number of lysosomes and 
the presence of lysosomal structures were increased (Fig. 30). It was tempting to speculate 
that ABCB6 may be involved in this process either by regulating lysosome activity or by 
influencing inter-organelle interactions between lysosomes and early melanosomes. A 
recent study strengthens our hypothesis, in which the authors observed that the substrate 
PMEL, localized to stage I melanosomes is processed by lysosomal proteases through 




“kiss-and-run” supports the role of stage I melanosomes as a crossroad between 
melanosomal and endolysosomal pathways199. 
DUH skin biopsies indicated a normal number of intact melanocytes in both hypo- 
and hyper-pigmented skin areas, a lower number of mature melanosomes in hypo-
pigmented macules and an accumulation of pigmented melanosomes in melanocytes and 
in keratinocytes in hyper-pigmented macules177. 
At the same time, we cannot exclude the possibility that the DUH phenotype is due 
to a defect in the transfer of mature melanosomes to keratinocytes. To exclude this a 
different model system would be needed. Once transferred to keratinocytes, melanosomes 
are either stored in non-degradative compartments or degraded by lysosomal hydrolases. 
It is also possible that ABCB6 influences these events through its expression and function 
in lysosomes of keratinocytes201–203. 
 
5.3. MNT-1 cell lines genome edited by CRISPR/Cas9 
A further new experimental model was established in this study where CRISPR 
genome editing method was used to assess the localization and function of endogenously 
regulated gene. Artificially overexpress a protein is not always expedient, especially in 
localization studies. It has a risk that a membrane transporter may appear in incorrect 
membrane structures, misleading the conclusion about the function. We should be aware 
that we may detect lysosomal localization due to overproduction and degradation. 
Because of this, we wanted to detect the intracellular distribution of ABCB6 using the 
latest gene editing method and suggest a functional model explaining the DUH 
phenotype. Frist, we performed FISH analysis to ascertain the copy number of the gene 
of interest. Results indicated that MNT-1 cells have four ABCB6 alleles. Then, we created 
different cell lines modifying ABCB6 at genomic level. At first, the lysosomal localization 
of the transporter was verified by a GFP tag fused to endogenous ABCB6 gene by CRISPR 
method in MNT-1 cells. (Fig. 32). For more detailed analysis of ABCB6 trafficking 
between cellular compartments we applied RUSH system. By applying an additional SBP 
tag upstream to GFP sequence in genetic code of ABCB6 we could establish a RUSH 
system for analysis the process. We are currently in the preliminary stages of 
experimentation, when the hook peptide is not expressed in the cells. We confirmed that 




lysosomal localization. These were in line with the previous results of the group. 
Investigating synchronized trafficking of ABCB6 remains a task for the future. Parallel 
with localization experiments, ABCB6 knock out cell line was generated for functional 
studies. We exploited the four SBP-GFP tagged alleles, as followed by ceasing of green 
fluorescent signal. Clones were validated at genomic and at protein level as well (Fig. 
34). We hypothesized that elimination of ABCB6 from a highly pigmented melanoma 
cell line will alter the melanotic feature of the cells. But measuring the melanin levels of 
parental, ABCB6 overexpressed, and ABCB6-KO cell lines were hardly conclusive. The 
knockdown of ABCB6 did not clearly reduce the melanin content of MNT-1 cells (Fig. 
36). This is consistent with results obtained by RNA silencing of ABCB6 (Fig. 24). 
Although pigmentation problems associated with ABCB6 probably connected to 
melanosome function current experiments were unable to clearly identify the function of 
this transporter. Understanding the relevance of ABCB6 in melanogenesis will require a 
better understanding of the function of ABCB6 in the endolysosomal system. ABCB6 
may be involved in regulating lysosomal activity or influencing inter-organelle 
interactions. We are speculating that based on our experiments in orthologue organisms 
we have to investigate more thoroughly the endolysosomal metal homeostasis to 
understand the role of ABCB6. Unfortunately, we still do not know the physiological 
substrate of ABCB6 in mammalian cells, but identification of possible substrates is an 






The intracellular localization of ABCB6 has been a matter of debate, with 
conflicting reports suggesting mitochondrial or endolysosomal localization. ABCB6 
shows significant sequence identity to HMT-1 (heavy metal tolerance factor 1) proteins, 
whose evolutionarily conserved role is to confer tolerance to heavy metals through the 
intracellular sequestration of metal complexes. We hypothesized that the cadmium-
sensitive phenotype of S. pombe and C. elegans strains defective for HMT-1 can be 
rescued by the human ABCB6 protein. It may be argued that the precise intracellular 
localization can only be established with the discovery of a matching physiological 
function. First, we showed that ABCB6 localizes to the same intracellular compartment 
as HMT-1 in these models, performing an overlapping function linked to the intracellular 
sequestration of metal complexes. Second, we revealed that ABCB6 rescues the Cd-
sensitive phenotype of HMT-1-deficient S. pombe and C. elegans strains. Third, we 
provided evidence that ABCB6 modulates the cadmium sensitivity of human 
glioblastoma cells. Determining the subcellular localization of a protein is a key step 
toward understanding its cellular function. Based on our previous results ABCB6 
undoubtedly traffics through the ER, as it exists as an N-glycosylated protein67. Similar 
to ABCB6, HMT-1 lacking the NTE domain was targeted to the plasma membrane, and 
did not confer tolerance to Cd95. In addition to evidence based on imaging of ABCB6 in 
organisms, in our work we provided functional proof supporting the role of ABCB6 in 
the vacuolar/endosomal sequestration of cadmium132.  
In 2013, it was published, that there is a link between certain ABCB6 mutations and 
the pigmentary disorder DUH30. The disease shows autosomal dominant inheritance, but 
the mechanism how ABCB6 affects skin pigmentation is not known. Therefore, in an 
attempt to understand the link between ABCB6 mutations and the DUH phenotype, we 
investigated the subcellular localization and function of ABCB6 in a human melanocytic 
cell line MNT-1. Consistent with our other results we corroborated the localization of 
ABCB6 in the endolysosomal continuum24,67,132. Endogenous ABCB6 was localized to 
lysosomes and early melanosomes, which was validated by the examination of GFP 
labeled endogenous protein created by the latest genome editing method. ABCB6 
depletion in melanoma cells resulted decreased amyloid formation, and the appearance 




inactive K562M mutant variant also induced the accumulation of unpigmented aberrant 
melanosomes and could not restore normal biogenesis of PMEL fibrils. We speculated 
that ABCB6 affects the generation of amyloidogenic fragments or their aggregation into 
fibrils. Although we have found a slight but significant effect of ABCB6 in melanoma 
cell line in vivo data shows even less effect. It is known that total lack of ABCB6 in 
humans (Lan negative phenotype) does not cause any problem and ABCB6 knockout 
mice show no pathologic phenotype either in skin68. But there is a well-marked difference 
in the ultrastructure of the retinal pigment epithelium, where the density of melanosomes 
in ABCB6+/− and ABCB6−/− mice was significantly lower193. Given the rare occurrence 
of Cd in mammalian cells, we believe that ABCB6 is involved in certain metal-complex 
transport in the lysosomal system. Since stage I melanosomes are at the crossroad of 
melanosomal and endolysosomal pathways199 ABCB6 may also play a role in melanin-
forming activity of melanocytes linked to a cell specific endolysosomal function. Based 
on our research, we assume that the function of ABCB6 is not related to the mitochondria 
but to the endolysosomal compartment. However, further studies are needed to 






In the human genome 48 different ABC (ATP binding cassette) proteins have been 
defined. In my PhD work I studied ABCB6, member of ABCB subfamily. Intracellular 
localization of ABCB6 has been a matter of debate. Our laboratory has provided evidence to 
support the endolysosomal localization of the protein, however, the physiological function of 
ABCB6 has remained elusive. My overall aim was to study the function and the 
pathophysiological role of ABCB6.  
ABCB6 shows significant sequence identity to HMT-1 (heavy metal tolerance factor-
1) proteins, whose role in lower organisms is to confer tolerance to heavy metals through 
intracellular sequestration of metal complexes. To examine the relation between ABCB6 and 
HMT-1 proteins, human ABCB6 was heterologously expressed in model organisms. We 
showed that ABCB6 rescues the Cd-sensitive phenotype of HMT-1-deficient S. pombe and 
C. elegans strains. In addition, ABCB6 is located in the lysosomes of human glioblastoma 
cells and increased cadmium tolerance of the cells.  
However, absence of the protein does not lead to pathological changes, genetic studies 
revealed that mutations in ABCB6 can cause distinct phenotypes: familial 
pseudohyperkalemia, ocular coloboma or DUH. DUH (Dyschromatosis universalis 
hereditaria) is a pigmentary genodermatosis with hyperpigmented and hypopigmented 
macules on the skin. To decipher the role of ABCB6 in melanogenesis, we expressed wild-
type and mutant ABCB6 in MNT-1 melanoma cell line, which are widely used to model 
pigmentation processes. We showed that ABCB6 is localized to lysosomes and early 
melanosomes of MNT-1 cells. Early melanosomes are at the crossroad between melanosomal 
and endolysosomal pathways, where fibril formation is initiated. Downregulation of ABCB6 
in MNT-1 cells resulted in decreased amyloid formation, and the appearance of proteo-lipid 
aggregates in early and mature melanosomes. In case of the expression of the mutant variants, 
similar aberrant structures were observed.  
To summarize, we provided functional proof supporting the role of ABCB6 in the 
vacuolar/endosomal sequestration of cadmium. Furthermore, we showed that ABCB6 is 
expressed in lysosomes and early melanosomes of pigment cells and regulate early steps of 
melanogenesis. Our results provide functional evidence linking ABCB6 to endolysosomal 
compartment. This paves the way for further research to fully understand the 






A humán genomban 48 ABC (ATP-kötő kazetta) fehérjét azonosítottak, melyek 
közül doktori munkám során a „B” alcsalád egy tagját, az ABCB6-ot tanulmányoztam. 
Az ABCB6 sejten belüli elhelyezkedése régóta vita tárgyát képezi. Az évek során 
kutatócsoportunk számos bizonyítékot szolgáltatott az ABCB6 endolizoszómális 
jelenlétére, azonban a fehérje élettani szerepe továbbra is kérdéses.  Kutatásom során a 
célom az ABCB6 működésének és patofiziológiai szerepének tanulmányozása volt.  
Filogenetikai elemzések alapján az ABCB6 jelentős szekvenciális hasonlóságot 
mutat a HMT-1 (nehézfém tolerancia faktor-1) fehérjecsaláddal, melyek alacsonyabb 
rendű élőlényekben nyújtanak védelmet a fémek intracelluláris transzportja révén. Az 
ABCB6 és a HMT-1 fehérjék kapcsolatának vizsgálatához a humán ABCB6-t heterológ 
módon termeltettük modell organizmusokban. Eredményeink alapján azt láttuk, hogy az 
ABCB6 képes menekíteni a HMT-1-hiányos S. pombe és C. elegans törzsek Cd-érzékeny 
fenotípusát. Ezen túlmenően az ABCB6 a humán glioblastoma sejtek lizoszómáiban 
lokalizálódott és képes volt fokozott Cd toleranciát biztosítani a sejteknek.  
Annak ellenére, hogy a fehérje hiánya nem vezet kóros következményekhez, 
genetikai elemzések kimutatták, hogy az ABCB6 mutációihoz többféle fenotípus is 
köthető: coloboma, familiáris pszeudohyperkalémia és a DUH. A DUH (Dyschromatosis 
universalis hereditaria) egy pigmentációs zavar, melynél a bőrön hiper- vagy 
hypopigmentált foltok figyelhetőek meg. Az ABCB6 melanogenezisben betöltött 
szerepének megfejtéséhez humán melanóma sejtben (MNT-1) vizsgáltuk a vad típusú és 
a mutáns ABCB6 változatokat. Megmutattuk, hogy az ABCB6 az MNT-1 sejtek 
lizoszómáiban és korai melanoszómáiban fordul elő. Az ABCB6 csendesítése során a 
sejtek korai és érett melanoszómáiban csökkent fibrillumképződést és fehérje-lipid 
aggregátumok megjelenését tapasztaltuk. A mutáns variánsok expressziója esetén 
hasonló aberráns struktúrák voltak megfigyelhetőek, tehát a mutáns fehérjék nem voltak 
képesek helyreállítani a normális fibrillum és melanoszóma képződést.  
Kutatásaink alapján azt mondhatjuk, hogy az ABCB6 funkciója az 
endolizoszomális kompartmenthez kötődik, szerepet játszik a Cd intracelluláris 
detoxifikációjában, valamint melanoma sejtekben a lizoszómákban és korai 
melanoszómáiban található. Ahhoz viszont, hogy az ABCB6 patofiziológiai szerepét 
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B6 seq 1 gcatggtgactgtcggaaac 
B6 seq 2 gcgagattttggtcgtaagttg 
B6 seq 3 cttggacttttggccggatc 
Seq B6 rev out cgacagtccatcctgcatcc 
Seq mCh fw cggaagatactaagccacagac 




pRH21-daf7_FW   cgactgcccggttcagcccgcttgaagttc 
ABCB6 Ce seq1 cccatcgtctctctccactgtt 









ABCB6 stop target 1 oligo 1 cacctgtcaccgttccatggtctg 
ABCB6 stop target 1 oligo 2 aaacagaccatggaacggtgaca 
ABCB6 stop target 2 oligo 1 caccatggaacggtgacaaaagtt 
ABCB6 stop target 2 oligo 2 aaacaacttttgtcaccgttccat 
ABCB6 stop target 3 oligo 1 caccaaacttttgtcaccgttcca 
ABCB6 stop target 3 oligo 2 aaactggaacggtgacaaaagttt 
ABCB6 stop target 4 oligo 1 caccgttagtctttgagagggaag 
ABCB6 stop target 4 oligo 2 aaaccttccctctcaaagactaac 
ABCB6 KO target 1 oligo1 caccgcacggcagcgtctggcaat 
ABCB6 KO target 1 oligo2 aaacattgccagacgctgccgtgc 
ABCB6 KO target 2 oligo1 caccgcctcgacgcggatggctctg 
ABCB6 KO target 2 oligo2 aaaccagagccatccgcgtcgaggc 
ABCB6 KO target 3 oligo1 caccgctcgtgccctcgacgcgga 
ABCB6 KO target 3 oligo2 aaactccgcgtcgagggcacgagc 
ABCB6 KO target 4 oligo1 caccggcgtttgcagctgagaact 
ABCB6 KO target 4 oligo2 aaacagttctcagctgcaaacgcc 
Sequencing 
primers 
B6 HRkar-genomi-fw-1 cgtcagcgctggatacatct 
B6 HRkar-genomi-rev-1 agccgtgtcaagaatgctca 
B6 HRkar-genomi-fw-2 tggagaggggacggtaagag 
B6 HRkar-genomi-rev-2 gcagtaccccatcccacaaa 
B6 HR-GFP-genomi-fw-1 aggtcttctgaattgggggc 
B6 HR-GFP-genomi-rev-1 ccgtttacgtcgccgtcc 
B6 HR-GFP-genomi-fw-2 agatccgccacaacatcgag 
B6 HR-GFP-genomi-rev-2 agccgtgtcaagaatgctca 
ABCB6-HRout1 acccaccttgtagtgttgct 
ABCB6-HRout2 gcccaacacacacagatcaga 
Abcb6 seq fw 1.0 catggtgactgtgggcaact 
AmpStop fw zsofi gtcaggcaactatggatgaacg 
TagBFP rev zsofi ccaccttgattctcatggtctgg 
CMV rev zsofi gtgggcagtttaccgtaaatactc 
Ori rev zsofi ctacagcgtgagctatgagaaagc 









Supplementary Table 2. Plasmid constructs 





















pPD95.75-Hmt1 promoter-B6-opt  









ultimate target + BFP coding 
plasmid  pCMV-tagBFP_U6 
GFP between homologous arms  pCDNA3-HR kar-GFP-HR kar 
ABCB6 gRNA coding plasmid 
pColEI_U6-ABCB6 stop spacer 1-
gRNA_CBH-mCh 
ABCB6 gRNA coding plasmid 
pColEI_U6-ABCB6 stop spacer 2-
gRNA_CBH-mCh 
ABCB6 gRNA coding plasmid 
pColEI_U6-ABCB6 stop spacer 3-
gRNA_CBH-mCh 
ABCB6 gRNA coding plasmid 
pColEI_U6-ABCB6 stop spacer 4-
gRNA_CBH-mCh 
SBP–GFP between homologous 
arms  pCDNA3-HR kar-SBP-GFP-HR kar 
wt SpCas9 coding plasmid px330_BglII 




wt SpCas9 + ABCB6-KO gRNA 
coding plasmid px330_ABCB6 KO target 1 
wt SpCas9 + ABCB6-KO gRNA 
coding plasmid px330_ABCB6 KO target 2 
wt SpCas9 + ABCB6-KO gRNA 
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Supplementary figure 1. Determination of 
the subcellular localization of ABCB6 by 
immunofluorescence labeling and laser-
scanning confocal microscopy. Expression 
of WT (ABCB6 WT), and mutant ABCB6 
variants (ABCB6 K629M and ABCB6 
G579E) was visualized in MNT-1 cells 
using the OSK ABCB6 antibody (green); 
nuclei were labeled with Hoechst 33342 
(blue); and organelles were labeled with 
specific markers (red): ER (Calnexin), 
Golgi (RCAS1), mitochondria (AIF), early 
endosomes (EEA1), lysosomes (LAMP1). 
Non-pigmented melanosomes were labeled 
using an antibody directed against the 
luminal domain of PMEL (Nki-beteb and 
HMB45); pigmented melanosomes were 
stained with TRP-1 (red). The scale bar 
represents 10 μm  
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